Document:

REGISTRATION
        RIGHTS AGREEMENT 

       

      This
        Registration Rights Agreement (this “Agreement”) is made and entered into as of
        April 27, 2006, by and between a21,
        Inc.,
        a
        Texas corporation (the “Company”), and Queequeg Partners, L.P. as agent (in such
        capacity “Agent”) for itself and the other holders of the Notes (collectively,
        the “Purchasers”). 

       

      This
        Agreement is made pursuant to the Securities Purchase Agreement (as amended,
        modified or supplemented from time to time, the “Securities Purchase Agreement”)
        and the Master Security Agreement (as amended, modified or supplemented from
        time to time, the “Security Agreement”), each dated as of the date hereof, by
        and among Agent, the Company and various subsidiaries of the Company, and
        pursuant to the Notes referred to therein.

       

      The
        Company and Agent hereby agree as follows: 

       

      1. Definitions.
        Capitalized terms used and not otherwise defined herein that are defined
        in the
        Security Agreement shall have the meanings given such terms in the Security
        Agreement. As used in this Agreement, the following terms shall have the
        following meanings: 

       

      “Board”
        means
        the
        Company’s Board of Directors.

       

      “Commission”
means
        the Securities and Exchange Commission.

       

      “Common
        Stock”
means
        shares of the Company’s common stock, par value $0.001 per share. 

       

      “Effectiveness
        Date”
means
        (i) with respect to the Registration Statement required to be filed pursuant
        to
        Section 2(a), a date no later than two hundred and seventy (270) days following
        the date hereof or (ii) with respect to a Registration Statement required
        to be
        filed pursuant to Section 2(b), a date no later than two hundred and seventy
        (270) days following the written demand of the applicable Holder provided,
        that,
        at the option of the Board by written notice to the Agent, if either (x)
        a
        Non-Disclosure Event or (y) a Significant Business Opportunity occurs during
        any
        two hundred and seventy (270) day period referred to in this clause (ii),
        such
        Effectiveness Date may be extended by the number of days the Non-Disclosure
        Event or the Significant Business Opportunity exists provided that the aggregate
        time period which such Effectiveness Date may be extended by (I) a
        Non-Disclosure Event pursuant to this clause (ii) shall not exceed forty
        (45)
        days in the aggregate and (II) a Significant Business Opportunity pursuant
        to
        this clause (ii) shall not exceed one hundred and eighty (180) days in the
        aggregate. Notwithstanding the foregoing, the Effectiveness Date in clause
        (ii)
        shall be extended (which extension shall be in addition to, and not in
        substitution of any extension described in clause (ii) above) by a number
        of
        days equal to the number of days the filing of the Registration Statement
        is
        delayed due to the objection of counsel of the Holder pursuant to Section
        2(b).

       

      “Effectiveness
        Period”
shall
        have the meaning set forth in Section 2(a). 

       

      “Event”
shall
        have the meaning set forth in Section 2(c).

      
        
          
          

        

        
          1

          
            

          

        

        
          
          

        

      

       

      “Event
        Date”
shall
        have the meaning set forth in Section 2(c).

       

      “Exchange
        Act”
means
        the Securities Exchange Act of 1934, as amended, and the rules and regulations
        promulgated thereunder.

       

      “Filing
        Date”
means
        a
        date no later than one hundred and eighty (180) days following the date hereof.
        

       

      “Holder”
or
        “Holders”
means
        the Purchasers or any of their respective affiliates or transferees to the
        extent any of them hold Registrable Securities.

       

      “Indemnified
        Party”
shall
        have the meaning set forth in Section 5(c).

       

      “Indemnifying
        Party”
shall
        have the meaning set forth in Section 5(c).

       

      “Liquidated
        Damages Percentage”
with
        respect to any Event shall mean (a) 0.5% during the period commencing on
        the
        Event Date and ending on the 30th
        calendar
        day following the Event Date, (b) 1% during the period commencing on the
        31st
        calendar
        day following the Event Date and ending on the 90th
        day
        following the Event Date and (c) 1.5% at all times after the 90th
        day
        following the Event Date. 

       

      “Non-Disclosure
        Event”
        means,
        other than a Significant Business Opportunity, there is material non-public
        information regarding the Company which would have to be disclosed in a
        Registration Statement and the Board reasonably determines not to be in the
        Company’s best interest to disclose and which the Company is not otherwise
        required to then disclose. 

       

      “Notes”
has
        the
        meaning set forth in the Security Agreement.

       

      “Proceeding”
means
        an action, claim, suit, investigation or proceeding (including, without
        limitation, an investigation or partial proceeding, such as a deposition),
        whether commenced or threatened. 

       

      “Prospectus”
means
        the prospectus included in a Registration Statement (including, without
        limitation, a prospectus that includes any information previously omitted
        from a
        prospectus filed as part of an effective registration statement in reliance
        upon
        Rule 430A promulgated under the Securities Act), as amended or supplemented
        by
        any prospectus supplement, with respect to the terms of the offering of any
        portion of the Registrable Securities covered by such Registration Statement,
        and all other amendments and supplements to the Prospectus, including
        post-effective amendments, and all material incorporated by reference or
        deemed
        to be incorporated by reference in such Prospectus. 

       

      “Registrable
        Securities”
means
        the shares of Common Stock issuable upon the conversion of each Note (which
        include the shares of Common Stock described in Section 2(b)
        hereof).

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      “Registration
        Statement”
means
        each registration statement required to be filed under the Securities Act
        that
        covers the resale of any Registrable Securities pursuant to the provisions
        of
        this Agreement, including the Prospectus therein, amendments and supplements
        to
        such registration statement or Prospectus, including pre- and post-effective
        amendments, all exhibits thereto, and all material incorporated by reference
        or
        deemed to be incorporated by reference in such registration statement.

       

      “Required
        Holders”
shall
        mean, at any time, the Holders of a majority in outstanding principal amount
        of
        the Notes.

       

      “Rule
        144”
means
        Rule 144 promulgated by the Commission pursuant to the Securities Act, as
        such
        Rule may be amended from time to time, or any similar rule or regulation
        hereafter adopted by the Commission having substantially the same effect
        as such
        Rule.

       

      “Rule
        415”
means
        Rule 415 promulgated by the Commission pursuant to the Securities Act, as
        such
        Rule may be amended from time to time, or any similar rule or regulation
        hereafter adopted by the Commission having substantially the same effect
        as such
        Rule.

       

      “Rule
        424”
means
        Rule 424 promulgated by the Commission pursuant to the Securities Act, as
        such
        Rule may be amended from time to time, or any similar rule or regulation
        hereafter adopted by the Commission having substantially the same effect
        as such
        Rule.

       

      “Securities
        Act”
means
        the Securities Act of 1933, as amended, and the rules and regulations
        promulgated thereunder.

       

      “Significant
        Business Opportunity” means
        a
        significant business opportunity (including, but not limited to, the acquisition
        or disposition of assets (other than in the ordinary course of business))
        or any
        merger, consolidation, tender offer or other similar transaction available
        to
        the Company which the Board reasonably determines not to be in the Company’s
        best interest to then disclose, and which the Company would be required to
        disclose in a Registration Statement.

       

      “Trading
        Market”
means
        any of the NASD OTC Bulletin Board, the Nasdaq Capital Market, the Nasdaq
        National Market, the American Stock Exchange or the New York Stock
        Exchange.

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      2. Registration.

       

      (a) On
        or
        prior to the Filing Date, the Company shall use commercially reasonable efforts
        to prepare and file with the Commission a Registration Statement covering
        the
        resale of the Registrable Securities for an offering to be made on a continuous
        basis (pursuant to Rule 415, if then applicable). Each Registration Statement
        shall be on a form then available to the Company. Subject to any comments
        by the
        Commission, such Registration Statement shall include the plan of distribution
        attached hereto as Exhibit
        A.
        Such
        Registration Statement also shall cover, to the extent allowable under the
        Securities Act and the rules promulgated thereunder (including Rule 416),
        such
        indeterminate number of additional shares of Common Stock resulting from
        stock
        splits, stock dividends or similar transactions with respect to the Additional
        Shares. Other than with respect to the securities listed on Exhibit
        C
        hereto,
        such Registration Statement shall not include any shares of Common Stock
        or
        other securities for the account of any other holder without the prior written
        consent of the Required Holders. The Registration Statement (and each amendment
        or supplement thereto, and each request for acceleration of effectiveness
        thereof) shall be provided to the Holders and their counsel no fewer than
        four
        (4) business days prior to their filing with the Commission, and the Company
        shall not file any document to which such counsel reasonably objects. The
        Company shall use its commercially reasonable efforts to cause each Registration
        Statement to become effective and remain effective as provided herein. The
        Company shall use commercially reasonable efforts to cause each Registration
        Statement to be declared effective under the Securities Act as promptly as
        possible after the filing thereof, but in any event no later than the
        Effectiveness Date. The Company shall use commercially reasonable efforts
        to
        keep each Registration Statement continuously effective under the Securities
        Act
        until the date which is the earlier date of when (i) all Registrable Securities
        covered by such Registration Statement have been sold or (ii) all Registrable
        Securities covered by such Registration Statement may be sold immediately
        pursuant to Rule 144(k) without registration under the Securities Act and
        without volume restrictions as determined by counsel to the Company pursuant
        to
        a written opinion letter to such effect, addressed and acceptable to the
        Company’s transfer agent and the affected Holders (each, an “Effectiveness
        Period”).

       

      (b) Within
        one hundred and twenty (120) days of the written demand of the Holders of
        a
        majority of the aggregate principal amount of the Notes, in the event of
        a
        change in the Fixed Conversion Price (as defined in the Securities Purchase
        Agreement) such that additional shares of Common Stock become issuable upon
        the
        due conversion of the Notes, the Company shall prepare and file with the
        Commission one or more Registration Statements on a form then available to
        the
        Company or amend the Registration Statement filed pursuant to clause (a)
        above,
        if such Registration Statement has not previously been declared effective
        (or on
        such form of registration statement as is then available to effect a
        registration for resale of such additional shares of Common Stock (the
“Additional Shares”), subject to the Required Holders’ consent) covering the
        resale of the Additional Shares, but only to the extent the Additional Shares
        are not at the time covered by an effective Registration Statement. Subject
        to
        any comments by the Commission, such Registration Statement shall include
        the
        plan of distribution attached hereto as Exhibit
        A.
        Such
        Registration Statement also shall cover, to the extent allowable under the
        Securities Act and the rules promulgated thereunder (including Rule 416),
        such
        indeterminate number of additional shares of Common Stock resulting from
        stock
        splits, stock dividends or similar transactions with respect to the Additional
        Shares. Other than with respect to the securities listed on Exhibit
        C
        hereto
        and securities included in registrations previously filed by the Company
        with
        the Commission, such Registration Statement shall not include any shares
        of
        Common Stock or other securities for the account of any other holder without
        the
        prior written consent of the Required Holders. The Registration Statement
        (and
        each amendment or supplement thereto, and each request for acceleration of
        effectiveness thereof) shall be provided to the Holders and their counsel
        no
        fewer than four (4) business days prior to their filing with the Commission,
        and
        the Company shall not file any document to which such counsel reasonably
        objects. 

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

       

      (c) If
        any
        Registration Statement required to be filed hereunder is not declared effective
        by the Commission by the Effectiveness Date (applicable to such Registration
        Statement) required hereby with respect to such Registration Statement (any
        such
        failure being referred to as an “Event,” and, the date on which such Event
        occurs, being referred to as “Event Date”), then, so long as such Event did not
        occur as the result of the action or inaction of any Holder or the Agent,
        until
        the applicable Event is cured or waived by the Required Holders, the Company
        shall, subject to the last sentence of this Section 2(c), pay to each Holder
        an
        amount in cash, as liquidated damages and not as a penalty, equal to the
        Liquidated Damages Percentage for each thirty (30) day period (prorated for
        partial periods) of the original principal amount of each applicable Note.
        While
        such Event continues, such liquidated damages shall be paid not less often
        than
        the first day of each calendar quarter. Any unpaid liquidated damages as
        of the
        date when an Event has been cured by the Company shall be paid on the first
        day
        of the next calendar quarter. Notwithstanding anything to the contrary, the
        maximum amount of liquidated damages paid by the Company pursuant to this
        Section 2(c) and Section 7(c) shall not exceed an aggregate of 24% of the
        aggregate amount invested by the Purchasers pursuant to the Securities Purchase
        Agreement.

       

      (d) Within
        three (3) business days of the Effectiveness Date, the Company shall cause
        its
        counsel to issue blanket instructions in the form attached hereto as
Exhibit
        B,
        to the
        transfer agent stating that the shares are subject to an effective registration
        statement and can be reissued free of restrictive legend upon notice of a
        sale
        by the Purchaser pursuant to the Registration Statement and confirmation
        by the
        Purchaser that it has complied with the prospectus delivery requirements,
        provided that the Company has not advised the transfer agent orally or in
        writing that the opinion has been withdrawn. Copies of the blanket opinion
        required by this Section 2(d) shall be delivered to the Agent within the
        time
        frame set forth above.

       

      (e) At
        any
        time after the date upon which the Company becomes eligible to use a
        registration statement on Form S-3 to register the Registrable Securities
        for
        resale, and provided the Company remains eligible to use Form S-3 to register
        resales of the Registrable Securities, the Company shall use commercially
        reasonable efforts to file any new Registration Statement and file any
        post-effective amendments to any Registration Statement on Form S-3. In
        addition, in the event that any Registration Statement has not yet been declared
        effective by the Commission, and provided the Company remains eligible to
        use
        Form S-3 to register resales of the Registrable Securities, the Company shall
        file an amendment to such pre-effective registration Statement on Form
        S-3.

       

      3. Registration
        Procedures.
        If and
        whenever the Company is required by the provisions hereof to effect the
        registration of any Registrable Securities under the Securities Act, the
        Company
        will, as expeditiously as possible: 

      
        
          
          

        

        
          5

          
            

          

        

        
          
          

        

      

       

      (a) prepare
        and file with the Commission a Registration Statement with respect to such
        Registrable Securities, respond as promptly as commercially reasonable to
        any
        comments received from the Commission, and use its commercially reasonable
        efforts to cause such Registration Statement to become and remain effective
        for
        the Effectiveness Period with respect thereto, and promptly provide to the
        Agent
        copies of all filings and Commission letters of comment relating thereto
        provided that such letters do not contain material non-public information,
        in
        which case such letters may be redacted by the Company;

       

      (b) prepare
        and file with the Commission such amendments and supplements to such
        Registration Statement and the Prospectus used in connection therewith as
        may be
        necessary to comply with the provisions of the Securities Act with respect
        to
        the disposition of all Registrable Securities covered by such Registration
        Statement and to keep such Registration Statement effective until the expiration
        of the Effectiveness Period applicable to such Registration
        Statement;

       

      (c) furnish
        to each Holder such number of copies of the Registration Statement and the
        Prospectus included therein (including each preliminary Prospectus) as such
        Holder reasonably may request to facilitate the public sale or disposition
        of
        the Registrable Securities covered by such Registration Statement;

       

      (d) use
        its
        commercially reasonable efforts to register or qualify each Holder’s Registrable
        Securities covered by such Registration Statement under the securities or
“blue
        sky” laws of such jurisdictions within the United States as such Holder may
        reasonably request, provided, however, that the Company shall not for any
        such
        purpose be required to qualify generally to transact business as a foreign
        corporation in any jurisdiction where it is not so qualified or to consent
        to
        general service of process in any such jurisdiction;

       

      (e) list
        the
        Registrable Securities covered by such Registration Statement with any
        securities exchange on which the Common Stock of the Company is then listed;
        

       

      (f) immediately
        notify the Agent at any time when a Prospectus relating thereto is required
        to
        be delivered under the Securities Act, of the happening of any event of which
        the Company has knowledge as a result of which the Prospectus contained in
        such
        Registration Statement, as then in effect, includes an untrue statement of
        a
        material fact or omits to state a material fact required to be stated therein
        or
        necessary to make the statements therein not misleading in light of the
        circumstances then existing; 

       

      (g) make
        available for inspection by any Holder and any attorney, accountant or other
        agent retained by the Agent on behalf of Holders, all publicly available,
        non-confidential financial and other records, pertinent corporate documents
        and
        properties of the Company, and cause the Company’s officers, directors and
        employees to supply all publicly available, non-confidential information
        reasonably requested by the attorney, accountant or agent of the Agent;

      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

       

      (h) otherwise
        use commercially reasonable efforts to comply with all applicable rules and
        regulations of the Securities Act and the Exchange Act, file any final
        Prospectus, including any supplement or amendment thereof, with the SEC pursuant
        to Rule 424 under the Securities Act, promptly inform the Holder in writing
        if,
        at any time during the Effectiveness Period, the Company does not satisfy
        the
        conditions specified in Rule 172 of the Securities Act and, as a result thereof,
        the Holders are required to deliver a Prospectus in connection with any
        disposition of Registrable Securities and take such other actions as may
        be
        reasonably necessary to facilitate the registration of the Registrable
        Securities hereunder; and make available to its security holders, as soon
        as
        reasonably practicable, but not later than the Availability Date (as defined
        below), an earnings statement covering a period of at least twelve (12) months,
        beginning after the effective date of each Registration Statement, which
        earnings statement shall satisfy the provisions of Section 11(a) of the
        Securities Act, including Rule 158 promulgated thereunder (for the purpose
        of
        this subsection 3(i), “Availability Date” means the 50th day following the end
        of the fourth fiscal quarter that includes the effective date of such
        Registration Statement, except that, if such fourth fiscal quarter is the
        last
        quarter of the Company’s fiscal year, “Availability Date” means the 105th day
        after the end of such fourth fiscal quarter); and

       

      (i) with
        a
        view to making available to the Holders the benefits of Rule 144 (or its
        successor rule) and any other rule or regulation of the Commission that may
        at
        any time permit the Holders to sell shares of Common Stock to the public
        without
        registration, the Company covenants and agrees to: (i) make and keep public
        information available, as those terms are understood and defined in Rule
        144,
        until the earlier of (A) one year after such date as all of the Registrable
        Securities may be resold pursuant to Rule 144(k) or any other rule of similar
        effect or (B) such date as all of the Registrable Securities shall have been
        resold; (ii) file with the Commission in a timely manner all reports and
        other
        documents required of the Company under the Exchange Act; and (iii) furnish
        to
        each Holder as promptly as practicable upon request, as long as such Holder
        owns
        any Registrable Securities, (A) a written statement by the Company that it
        has
        complied with the reporting requirements of the Exchange Act, and (B) such
        other
        information as may be reasonably requested in order to avail such Holder
        of any
        rule or regulation of the Commission that permits the selling of any such
        Registrable Securities without registration.

       

      4. Registration
        Expenses.
        All
        expenses relating to the Company’s compliance with Sections 2 and 3 hereof,
        including, without limitation, all registration and filing fees, printing
        expenses, fees and disbursements of counsel and independent public accountants
        for the Company, fees and expenses (including reasonable counsel fees) incurred
        in connection with complying with state securities or “blue sky” laws, fees of
        the NASD, transfer taxes, fees of transfer agents and registrars, fees of,
        and
        disbursements incurred by, one counsel for the Holders are called “Registration
        Expenses”. All selling commissions applicable to the sale of Registrable
        Securities, including any fees and disbursements of any special counsel to
        the
        Holders beyond those included in the Registration Expenses, are called “Selling
        Expenses.” The Company shall only be responsible for Registration
        Expenses.

      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

       

      5. Indemnification.

       

      (a) In
        the
        event of a registration of any Registrable Securities under the Securities
        Act
        pursuant to this Agreement, the Company will indemnify and hold harmless
        each
        Holder, and its officers, directors and each other person, if any, who controls
        such Holder within the meaning of the Securities Act, against any losses,
        claims, damages or liabilities, joint or several, to which such Holder, or
        such
        persons may become subject under the Securities Act or otherwise, insofar
        as
        such losses, claims, damages or liabilities (or actions in respect thereof)
        arise out of or are based upon any untrue statement or alleged untrue statement
        of any material fact contained in any Registration Statement under which
        such
        Registrable Securities were registered under the Securities Act pursuant
        to this
        Agreement, any preliminary Prospectus or final Prospectus contained therein,
        or
        any amendment or supplement thereof, or arise out of or are based upon the
        omission or alleged omission to state therein a material fact required to
        be
        stated therein or necessary to make the statements therein not misleading,
        and
        will reimburse such Holder, and each such person for any reasonable legal
        or
        other expenses incurred by them in connection with investigating or defending
        any such loss, claim, damage, liability or action; provided,
        however, that the Company will not be liable in any such case if and to the
        extent that any such loss, claim, damage or liability arises out of or is
        based
        upon (i) an untrue statement or alleged untrue statement or omission or alleged
        omission so made in conformity with information furnished by or on behalf
        of
        such Holder, any other Holder or any such person in writing or (ii) the use
        by
        such Holder, any other Holder or any such person of an outdated or defective
        prospectus (without any Company provided supplement correcting such outdated
        or
        defective prospectus) after the Company has notified such Holder or any person
        in writing that such prospectus is suspended from use, outdated or
        defective.

       

      (b) In
        the
        event of a registration of the Registrable Securities under the Securities
        Act
        pursuant to this Agreement, each Holder will indemnify and hold harmless
        the
        Company, its Subsidiaries and their respective officers, directors and each
        other person, if any, who controls the Company or any such Subsidiary within
        the
        meaning of the Securities Act, against all losses, claims, damages or
        liabilities, joint or several, to which the Company, any such Subsidiary
        or such
        persons may become subject under the Securities Act or otherwise, insofar
        as
        such losses, claims, damages or liabilities (or actions in respect thereof)
        arise out of or are based upon any untrue statement or alleged untrue statement
        of any material fact which was furnished in writing by the Purchaser to the
        Company (and such information is contained in) the Registration Statement
        under
        which such Registrable Securities were registered under the Securities Act
        pursuant to this Agreement, any preliminary Prospectus or final Prospectus
        contained therein, or any amendment or supplement thereof, or arise out of
        or
        are based upon the omission or alleged omission to state therein a material
        fact
        required to be stated therein or necessary to make the statements therein
        not
        misleading, and will reimburse the Company, its Subsidiaries and each such
        person for any reasonable legal or other expenses incurred by them in connection
        with investigating or defending any such loss, claim, damage, liability or
        action, provided, however, that such Holder will be liable in any such case
        if
        and only to the extent that any such loss, claim, damage or liability arises
        out
        of or is based upon an untrue statement or alleged untrue statement or omission
        or alleged omission so made in conformity with information furnished in writing
        to the Company or such Subsidiary by or on behalf of such Holder specifically
        for use in any such document or the use by such Holder of an outdated or
        defective prospectus (without the Company provided supplement correcting
        such
        outdated or defective prospectus) after the Company has notified such Holder
        in
        writing that such prospectus is suspended from use, outdated or defective.
        Notwithstanding the provisions of this paragraph, no Holder shall be required
        to
        indemnify any person or entity in excess of the amount of the aggregate net
        proceeds received by the Purchaser in respect of Registrable Securities in
        connection with any such registration under the Securities Act.

      
        
          
          

        

        
          8

          
            

          

        

        
          
          

        

      

       

      (c) Promptly
        after receipt by a party entitled to claim indemnification hereunder (an
        “Indemnified Party”) of notice of the commencement of any action, such
        Indemnified Party shall, if a claim for indemnification in respect thereof
        is to
        be made against a party hereto obligated to indemnify such Indemnified Party
        (an
“Indemnifying Party”), notify the Indemnifying Party in writing thereof, but the
        omission so to notify the Indemnifying Party shall not relieve it from any
        liability which it may have to such Indemnified Party other than under this
        Section 5(c) and shall only relieve it from any liability which it may have
        to
        such Indemnified Party under this Section 5(c) if and to the extent the
        Indemnifying Party is prejudiced by such omission. In case any such action
        shall
        be brought against any Indemnified Party and it shall notify the Indemnifying
        Party of the commencement thereof, the Indemnifying Party shall be entitled
        to
        participate in and, to the extent it shall wish, to assume and undertake
        the
        defense thereof with counsel satisfactory to such Indemnified Party, and,
        after
        notice from the Indemnifying Party to such Indemnified Party of its election
        so
        to assume and undertake the defense thereof, the Indemnifying Party shall
        not be
        liable to such Indemnified Party under this Section 5(c) for any legal expenses
        subsequently incurred by such Indemnified Party in connection with the defense
        thereof; if the Indemnified Party retains its own counsel, then the Indemnified
        Party shall pay all fees, costs and expenses of such counsel, provided,
        however, that, if the defendants in any such action include both the indemnified
        party and the Indemnifying Party and the Indemnified Party shall have reasonably
        concluded that there may be reasonable defenses available to it which are
        different from or additional to those available to the Indemnifying Party
        or if
        the interests of the Indemnified Party reasonably may be deemed to conflict
        with
        the interests of the Indemnifying Party, the Indemnified Party shall have
        the
        right to select separate counsel and to assume such legal defenses and otherwise
        to participate in the defense of such action, with the reasonable expenses
        and
        fees of such separate counsel and other expenses related to such participation
        to be reimbursed by the Indemnifying Party as incurred. 

       

      (d) In
        order
        to provide for just and equitable contribution in the event of joint liability
        under the Securities Act in any case in which either (i) any Holder, or any
        officer, director or controlling person of such Holder, makes a claim for
        indemnification pursuant to this Section 5 but it is judicially determined
        (by
        the entry of a final judgment or decree by a court of competent jurisdiction
        and
        the expiration of time to appeal or the denial of the last right of appeal)
        that
        such indemnification may not be enforced in such case notwithstanding the
        fact
        that this Section 5 provides for indemnification in such case, or (ii)
        contribution under the Securities Act may be required on the part of such
        Holder
        or such officer, director or controlling person of such Holder in circumstances
        for which indemnification is provided under this Section 5; then, and in
        each
        such case, the Company and such Holder will contribute to the aggregate losses,
        claims, damages or liabilities to which they may be subject (after contribution
        from others) in such proportion so that such Holder is responsible only for
        the
        portion represented by the percentage that the public offering price of its
        securities offered by the Registration Statement bears to the public offering
        price of all securities offered by such Registration Statement, provided,
        however, that, in any such case, (A) such Holder will not be required to
        contribute any amount in excess of the public offering price of all such
        securities offered by it pursuant to such Registration Statement; and (B)
        no
        person or entity guilty of fraudulent misrepresentation (within the meaning
        of
        Section 10(f) of the Act) will be entitled to contribution from any person
        or
        entity who was not guilty of such fraudulent misrepresentation.

      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

       

      6. Representations
        and Warranties.

       

      (a) The
        Common Stock of the Company is registered pursuant to Section 12(b) or 12(g)
        of
        the Exchange Act and, to the Security Agreement, the Company has, as of the
        date
        hereof, filed all proxy statements, reports, schedules, forms, statements
        and
        other documents required to be filed by it under the Exchange Act. The Company
        has filed (i) its Annual Report on Form 10-KSB for the fiscal year ended
        December 31, 2004 and (ii) its Quarterly Report on Form 10-QSB for the fiscal
        quarters ended September 30, 2005 (the “SEC Reports”). Each SEC Report was, at
        the time of its filing, in substantial compliance with the requirements of
        its
        respective form and included as exhibits thereto all exhibits required to
        be
        filed therewith or incorporated therein by reference, and none of the SEC
        Reports, nor the financial statements (and the notes thereto) included in
        the
        SEC Reports, as of their respective filing dates, contained any untrue statement
        of a material fact or omitted to state a material fact required to be stated
        therein or necessary to make the statements therein, in light of the
        circumstances under which they were made, not misleading. The financial
        statements of the Company included in the SEC Reports comply as to form in
        all
        material respects with applicable accounting requirements and the published
        rules and regulations of the Commission or other applicable rules and
        regulations with respect thereto. Such financial statements have been prepared
        in accordance with generally accepted accounting principles (“GAAP”) applied on
        a consistent basis during the periods involved (except (i) as may be otherwise
        indicated in such financial statements or the notes thereto or (ii) in the
        case
        of unaudited interim statements, to the extent they may not include footnotes
        or
        may be condensed) and fairly present in all material respects the financial
        condition, the results of operations and the cash flows of the Company and
        its
        subsidiaries, on a consolidated basis, as of, and for, the periods presented
        in
        each such SEC Report.

       

      (b) The
        Common Stock is quoted on the NASD OTC Bulletin Board. The Company has not
        received any notice that its Common Stock will no longer be quoted on the
        NASD
        OTC Bulletin Board or that the Common Stock does not meet all requirements
        for
        the continuation of such quotation.

       

      (c) Neither
        the Company, nor any of its affiliates, nor any person acting on its or their
        behalf, has directly or indirectly made any offers or sales of any security
        or
        solicited any offers to buy any security under circumstances that would cause
        the offering of the Securities pursuant to the Security Agreement to be
        integrated with prior offerings by the Company for purposes of the Securities
        Act which would prevent the Company from selling the Common Stock pursuant
        to
        Rule 506 under the Securities Act, or any applicable exchange-related
        stockholder approval provisions, nor will the Company or any of its affiliates
        or subsidiaries take any action or steps that would cause the offering of
        the
        Common Stock to be integrated with other offerings (other than such concurrent
        offering to the Purchaser).

      
        
          
          

        

        
          10

          
            

          

        

        
          
          

        

      

       

      (d) The
        Company understands the nature of the Registrable Securities issuable upon
        the
        conversion of each Note and recognizes that the issuance of such Registrable
        Securities may have a potential dilutive effect. The Company specifically
        acknowledges that its obligation to issue the Registrable Securities is binding
        upon the Company and enforceable regardless of the dilution such issuance
        may
        have on the ownership interests of other shareholders of the
        Company.

       

      7. Miscellaneous.

       

      (a) Remedies.
        In the
        event of a breach by the Company or by a Holder, of any of their respective
        obligations under this Agreement, the Agent, at the direction of Required
        Holders, or the Company, as the case may be, in addition to being entitled
        to
        exercise all rights granted by law and under this Agreement, including recovery
        of damages, will be entitled to specific performance of its rights under
        this
        Agreement.

       

      (b) Compliance.
        Each
        Holder covenants and agrees that it will comply with the prospectus delivery
        requirements of the Securities Act as applicable to it in connection with
        sales
        of Registrable Securities pursuant to any Registration Statement. 

       

      (c) Discontinued
        Disposition.
        Each
        Holder agrees by its acquisition of such Registrable Securities that, upon
        receipt of a notice from the Company of the occurrence of a Discontinuation
        Event (as defined below), such Holder will forthwith discontinue disposition
        of
        such Registrable Securities under the applicable Registration Statement until
        such Holder’s receipt of the copies of the supplemented Prospectus and/or
        amended Registration Statement or until it is advised in writing (the “Advice”)
        by the Company that the use of the applicable Prospectus may be resumed (each
        a
“Discontinuation Period”), and, in either case, has received copies of any
        additional or supplemental filings that are incorporated or deemed to be
        incorporated by reference in such Prospectus or Registration Statement;
        provided, however, that the aggregate number of Discontinuation Periods may
        not
        exceed the Discontinuation Maximum (as defined below) in any twelve month
        period; and provided further that in the event that the Discontinuation Period
        exceeds the Discontinuation Maximum in any twelve month period, until the
        Holders are able to sell the Registrable Securities pursuant to a Registration
        Statement or pursuant to Rule 144, the Company shall, subject to the last
        sentence of this Section 7(c), pay to each Holder an amount in cash, as
        liquidated damages and not as a penalty, equal to the Liquidated Damages
        Percentage for each thirty (30) day period (prorated for partial periods)
        of the
        original principal amount of each applicable Note. While such Discontinuation
        Period continues, such liquidated damages shall be paid not less often than
        the
        first day of each calendar quarter. Any unpaid liquidated damages as of the
        date
        when the Holders are again able to sell the Registrable Securities pursuant
        to a
        Registration Statement shall be paid on the first day of the next calendar
        quarter. The Company may provide appropriate stop orders to enforce the
        provisions of this paragraph. Notwithstanding anything to the contrary, the
        maximum amount of liquidated damages paid by the Company pursuant to this
        Section 7(c) and Section 2(c) shall not exceed an aggregate of 24% of the
        aggregate amount invested by the Purchasers pursuant to the Securities Purchase
        Agreement.

      
        
          
          

        

        
          11

          
            

          

        

        
          
          

        

      

       

      i. Notwithstanding
        the foregoing, in the event that there is a Discontinuation Event prior to
        the
        latest date permitted by the definition of Effectiveness Date of any
        Registration Statement, the Company will not be considered to have exceeded
        the
        Discontinuation Maximum for such Registration Statement until the later of
        (i)
        the latest date permitted by the definition of Effectiveness Date for such
        Registration Statement, or (ii) 120 days after the date of the Discontinuation
        Event.

       

      ii. For
        purposes of Section 7(c), a “Discontinuation Event” shall mean (i) when the
        Commission notifies the Company whether there will be a “review” of such
        Registration Statement and whenever the Commission comments in writing on
        such
        Registration Statement (the Company shall provide true and complete copies
        thereof and all written responses thereto to the Agent); (ii) any request
        by the
        Commission or any other federal or state governmental authority for amendments
        or supplements to such Registration Statement or Prospectus or for additional
        information; (iii) the issuance by the Commission of any stop order suspending
        the effectiveness of such Registration Statement covering any or all of the
        Registrable Securities or the initiation of any Proceedings for that purpose;
        (iv) the receipt by the Company of any notification with respect to the
        suspension of the qualification or exemption from qualification of any of
        the
        Registrable Securities for sale in any jurisdiction, or the initiation or
        threatening of any Proceeding for such purpose; and/or (v) the occurrence
        of any
        event or passage of time that makes the financial statements included in
        such
        Registration Statement ineligible for inclusion therein or any statement
        made in
        such Registration Statement or Prospectus or any document incorporated or
        deemed
        to be incorporated therein by reference untrue in any material respect or
        that
        requires any revisions to such Registration Statement, Prospectus or other
        documents so that, in the case of such Registration Statement or Prospectus,
        as
        the case may be, it will not contain any untrue statement of a material fact
        or
        omit to state any material fact required to be stated therein or necessary
        to
        make the statements therein, in light of the circumstances under which they
        were
        made, not misleading.

       

      iii. For
        purposes of Section 7(c), the “Discontinuation Maximum” shall mean (a) with
        respect to one or more Discontinuation Events that result from a Significant
        Business Opportunity, 120 days, or (b) with respect to any other Discontinuation
        Event, 60 days.

       

      (d) Piggy-Back
        Registrations.
        If at
        any time during any Effectiveness Period there is not an effective Registration
        Statement covering all of the Registrable Securities required to be covered
        during such Effectiveness Period and the Company shall determine to prepare
        and
        file with the Commission a registration statement relating to an offering
        for
        its own account or the account of others under the Securities Act of any
        of its
        equity securities, other than on Form S-4 or Form S-8 (each as promulgated
        under
        the Securities Act) or their then equivalents relating to equity securities
        to
        be issued solely in connection with any acquisition of any entity or business
        or
        equity securities issuable in connection with stock option or other employee
        benefit plans, then the Company shall send to each Holder written notice
        of such
        determination and, if within fifteen (15) days after receipt of such notice,
        any
        such Holder shall so request in writing, the Company shall include in such
        registration statement all or any part of such Registrable Securities such
        holder requests to be registered, to the extent the Company may do so without
        violating registration rights of others which exist as of the date of this
        Agreement, subject to customary underwriter cutbacks applicable to all holders
        of registration rights and subject to obtaining any required the consent
        of any
        selling stockholder(s) to such inclusion under such registration
        statement.

      
        
          
          

        

        
          12

          
            

          

        

        
          
          

        

      

       

      (e) Amendments
        and Waivers.
        The
        provisions of this Agreement, including the provisions of this sentence,
        may not
        be amended, modified or supplemented, and waivers or consents to departures
        from
        the provisions hereof may not be given, unless the same shall be in writing
        and
        signed by the Company and the Agent at the direction of Required Holders
        of the
        then outstanding Registrable Securities. 

       

      (f) Notices.
        Any
        notice or request hereunder may be given to the Company or the Agent at the
        respective addresses set forth below or as may hereafter be specified in
        a
        notice designated as a change of address under this Section 7(f). Any notice
        or
        request hereunder shall be given by registered or certified mail, return
        receipt
        requested, hand delivery, overnight mail or telecopy (confirmed by mail).
        Notices and requests shall be, in the case of those by hand delivery, deemed
        to
        have been given when delivered to any party to whom it is addressed, in the
        case
        of those by mail or overnight mail, deemed to have been given three (3) business
        days after the date when deposited in the mail or with the overnight mail
        carrier, and, in the case of a telecopy, when confirmed. The address for
        such
        notices and communications shall be as follows:

       

      
        	
                If
                  to the Company:

              	
                a21,
                  Inc.

              
	 	
                7660
                  Centurian Parkway

              
	 	
                Jacksonville,
                  Florida 32256

              
	 	
                Attention:
                  Chief Financial Officer

              
	 	
                Facsimile:
                  (904) 565-1620

              
	 	 
	
                With
                  a copy to:

              	
                Lloyd
                  L. Rothenberg, Esq.

              
	 	
                Loeb
&
Loeb,
                  LLP

              
	 	
                345
                  Park Avenue

              
	 	
                New
                  York, New York 10154

              
	 	
                Facsimile:
                  (212) 407-4990

              
	 	 
	
                If
                  to Agent:

              	
                To
                  the address set forth under

              
	 	
                the
                  Agent’s name on the

              
	 	
                signature
                  pages hereto.

              
	
              	 
	
                  If
                  to any other Person who is then the
                  registered Holder:

              
	 	 
	 	        To the address of
                such Holder as it
	 	       
                appears in the stock transfer books
	 	        of
                the Company

      

       

      or
        such
        other address as may be designated in writing hereafter in accordance with
        this
        Section 7(g) by such Person.

      
        
          
          

        

        
          13

          
            

          

        

        
          
          

        

      

       

      (g) Successors
        and Assigns.
        This
        Agreement shall inure to the benefit of and be binding upon the successors
        and
        permitted assigns of each of the parties and shall inure to the benefit of
        each
        Holder. The Company may not assign its rights or obligations hereunder without
        the prior written consent of the Agent. Each Holder may assign their respective
        rights hereunder in the manner and to the Persons as permitted under the
        Notes
        and the Securities Purchase Agreement with the prior written consent of the
        Company, which consent shall not be unreasonably withheld or delayed.

       

      (h) Execution
        and Counterparts.
        This
        Agreement may be executed in any number of counterparts, each of which when
        so
        executed shall be deemed to be an original and, all of which taken together
        shall constitute one and the same Agreement. In the event that any signature
        is
        delivered by facsimile transmission, such signature shall create a valid
        binding
        obligation of the party executing (or on whose behalf such signature is
        executed) the same with the same force and effect as if such facsimile signature
        were the original thereof.

       

      (i) Governing
        Law.
        All
        questions concerning the construction, validity, enforcement and interpretation
        of this Agreement shall be governed by and construed and enforced in accordance
        with the internal laws of the State of New York, without regard to the
        principles of conflicts of law thereof. Each party agrees that all Proceedings
        concerning the interpretations, enforcement and defense of the transactions
        contemplated by this Agreement shall be commenced exclusively in the state
        and
        federal courts sitting in the City of New York, Borough of Manhattan. Each
        party
        hereto hereby irrevocably submits to the exclusive jurisdiction of the state
        and
        federal courts sitting in the City of New York, Borough of Manhattan for
        the
        adjudication of any dispute hereunder or in connection herewith or with any
        transaction contemplated hereby or discussed herein, and hereby irrevocably
        waives, and agrees not to assert in any Proceeding, any claim that it is
        not
        personally subject to the jurisdiction of any such court, that such Proceeding
        is improper. Each party hereto hereby irrevocably waives personal service
        of
        process and consents to process being served in any such Proceeding by mailing
        a
        copy thereof via registered or certified mail or overnight delivery (with
        evidence of delivery) to such party at the address in effect for notices
        to it
        under this Agreement and agrees that such service shall constitute good and
        sufficient service of process and notice thereof. Nothing contained herein
        shall
        be deemed to limit in any way any right to serve process in any manner permitted
        by law. Each party hereto hereby irrevocably waives, to the fullest extent
        permitted by applicable law, any and all right to trial by jury in any legal
        proceeding arising out of or relating to this Agreement or the transactions
        contemplated hereby. If either party shall commence a Proceeding to enforce
        any
        provisions of this Agreement, then the prevailing party in such Proceeding
        shall
        be reimbursed by the other party for its reasonable attorneys fees and other
        costs and expenses incurred with the investigation, preparation and prosecution
        of such Proceeding.

       

      (j) Cumulative
        Remedies.
        The
        remedies provided herein are cumulative and not exclusive of any remedies
        provided by law.

      
        
          
          

        

        
          14

          
            

          

        

        
          
          

        

      

       

      (k) Severability.
        If any
        term, provision, covenant or restriction of this Agreement is held by a court
        of
        competent jurisdiction to be invalid, illegal, void or unenforceable, the
        remainder of the terms, provisions, covenants and restrictions set forth
        herein
        shall remain in full force and effect and shall in no way be affected, impaired
        or invalidated, and the parties hereto shall use their reasonable efforts
        to
        find and employ an alternative means to achieve the same or substantially
        the
        same result as that contemplated by such term, provision, covenant or
        restriction. It is hereby stipulated and declared to be the intention of
        the
        parties that they would have executed the remaining terms, provisions, covenants
        and restrictions without including any of such that may be hereafter declared
        invalid, illegal, void or unenforceable.

       

      (l) Headings.
        The
        headings in this Agreement are for convenience of reference only and shall
        not
        limit or otherwise affect the meaning hereof.

       

      [Balance
        of page intentionally left blank; signature page
        follows.]

      
        
          
          

        

        
          15

          
            

          

        

        
          
          

        

      

       

      IN
        WITNESS WHEREOF, the parties have executed this Registration Rights Agreement
        as
        of the date first written above.

       

      
        	
                QUEEQUEG
                  PARTNERS, L.P.,

              	 
	
                                                                                          as
                  Agent

              	 
	
                                                 By:
                  QUEEQUEG
                  GP, LLC,
                  its General Partner

              
	 	 
	
                                                                                                                    
                                                 
                  By: /s/ Jonathan Gallen

              
	                                                                                                                                    
                Name: Jonathan Gallen
	                                                                                                                                    
                Title: Managing Member
	 
	                                                                                                                                    
                Address for Notices:
	 
	                                                                                                                                    
                Queequeg Partners, L.P.
	                                                                                                                                    
                299 Park Avenue
	                                                                                                                                    
                New York, NY 10171
	 
	AGREED AND CONSENTED
                TO:                                                                        
                a21,
                INC.
	 
	                                                                                                                                    
                By: /s/ Tom Costanza 
	                                                                                                                                    
                Name: Tom Costanza 
	                                                                                                                                    
                Title: VP CFO
	 
	 
	                                                                                                                                    
                Address for Notices:
	 
	                                                                                                                                    
                7660 Centurian Parkway
	                                                                                                                                     Jacksonville,
                FL 32256

      

       

       

       

       

       

       

       

       

       

       

       

      

       

       

       

       

      
        
          
          

        

        
          16

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        A

       

      

       

      Plan
        of Distribution

       

      The
        selling stockholders, which as used herein includes donees, pledgees,
        transferees or other successors-in-interest selling shares of common stock
        or
        interests in shares of common stock received after the date of this prospectus
        from a selling stockholder as a gift, pledge, partnership distribution or
        other
        transfer, may, from time to time, sell, transfer or otherwise dispose of
        any or
        all of their shares of common stock or interests in shares of common stock
        on
        any stock exchange, market or trading facility on which the shares are traded
        or
        in private transactions. These dispositions may be at fixed prices, at
        prevailing market prices at the time of sale, at prices related to the
        prevailing market price, at varying prices determined at the time of sale,
        or at
        negotiated prices.

       

      The
        selling stockholders may use any one or more of the following methods when
        disposing of shares or interests therein:

       

      
        	
                -

              	
                ordinary
                  brokerage transactions and transactions in which the broker-dealer
                  solicits purchasers;

              
	 	 
	
                -

              	
                block
                  trades in which the broker-dealer will attempt to sell the shares
                  as
                  agent, but may position and resell a portion of the block as principal
                  to
                  facilitate the transaction;

              
	 	 
	
                -

              	
                purchases
                  by a broker-dealer as principal and resale by the broker-dealer
                  for its
                  account;

              
	 	 
	
                -

              	
                an
                  exchange distribution in accordance with the rules of the applicable
                  exchange;

              
	 	 
	
                -

              	
                privately
                  negotiated transactions;

              
	 	 
	
                -

              	
                short
                  sales effected after the date the registration statement of which
                  this
                  Prospectus is a part is declared effective by the
                  Commission;

              
	 	 
	
                -

              	
                through
                  the writing or settlement of options or other hedging transactions,
                  whether through an options exchange or otherwise;

              
	 	 
	
                -

              	
                the
                  sale of a specified number of such shares at a stipulated price
                  per share;
                  and

              
	 	 
	
                -

              	
                a
                  combination of any such methods of
                  sale.

              

      

       

      
        
          
          

        

        
          17

          
            

          

        

        
          
          

        

      

       

      The
        selling stockholders may, from time to time, pledge or grant a security interest
        in some or all of the shares of common stock owned by them and, if they default
        in the performance of their secured obligations, the pledgees or secured
        parties
        may offer and sell the shares of common stock, from time to time, under this
        prospectus, or under an amendment to this prospectus under Rule 424(b)(3)
        or
        other applicable provision of the Securities Act amending the list of selling
        stockholders to include the pledgee, transferee or other successors in interest
        as selling stockholders under this prospectus. The selling stockholders also
        may
        transfer the shares of common stock in other circumstances, in which case
        the
        transferees, pledgees or other successors in interest will be the selling
        beneficial owners for purposes of this prospectus.

       

      In
        connection with the sale of our common stock or interests therein, the selling
        stockholders may enter into hedging transactions with broker-dealers or other
        financial institutions, which may in turn engage in short sales of the common
        stock in the course of hedging the positions they assume. The selling
        stockholders may also sell shares of our common stock short and deliver these
        securities to close out their short positions, or loan or pledge the common
        stock to broker-dealers that in turn may sell these securities. The selling
        stockholders may also enter into option or other transactions with
        broker-dealers or other financial institutions or the creation of one or
        more
        derivative securities which require the delivery to such broker-dealer or
        other
        financial institution of shares offered by this prospectus, which shares
        such
        broker-dealer or other financial institution may resell pursuant to this
        prospectus (as supplemented or amended to reflect such
        transaction).

       

      The
        aggregate proceeds to the selling stockholders from the sale of the common
        stock
        offered by them will be the purchase price of the common stock less discounts
        or
        commissions, if any. Each of the selling stockholders reserves the right
        to
        accept and, together with their agents from time to time, to reject, in whole
        or
        in part, any proposed purchase of common stock to be made directly or through
        agents. We will not receive any of the proceeds from this offering. Upon
        any
        exercise of the warrants by payment of cash, however, we will receive the
        exercise price of the warrants.

       

      The
        selling stockholders also may resell all or a portion of the shares in open
        market transactions in reliance upon Rule 144 under the Securities Act of
        1933,
        provided that they meet the criteria and conform to the requirements of that
        rule.

       

      The
        selling stockholders and any underwriters, broker-dealers or agents that
        participate in the sale of the common stock or interests therein may be
        "underwriters" within the meaning of Section 2(11) of the Securities Act.
        Any
        discounts, commissions, concessions or profit they earn on any resale of
        the
        shares may be underwriting discounts and commissions under the Securities
        Act.
        Selling stockholders who are "underwriters" within the meaning of Section
        2(11)
        of the Securities Act will be subject to the prospectus delivery requirements
        of
        the Securities Act.

       

      To
        the
        extent required, the shares of our common stock to be sold, the names of
        the
        selling stockholders, the respective purchase prices and public offering
        prices,
        the names of any agents, dealer or underwriter, any applicable commissions
        or
        discounts with respect to a particular offer will be set forth in an
        accompanying prospectus supplement or, if appropriate, a post-effective
        amendment to the registration statement that includes this
        prospectus.

      
        
          
          

        

        
          18

          
            

          

        

        
          
          

        

      

       

      In
        order
        to comply with the securities laws of some states, if applicable, the common
        stock may be sold in these jurisdictions only through registered or licensed
        brokers or dealers. In addition, in some states the common stock may not
        be sold
        unless it has been registered or qualified for sale or an exemption from
        registration or qualification requirements is available and is complied
        with.

       

      We
        have
        advised the selling stockholders that the anti-manipulation rules of Regulation
        M under the Exchange Act may apply to sales of shares in the market and to
        the
        activities of the selling stockholders and their affiliates. In addition,
        to the
        extent applicable we will make copies of this prospectus (as it may be
        supplemented or amended from time to time) available to the selling stockholders
        for the purpose of satisfying the prospectus delivery requirements of the
        Securities Act. The selling stockholders may indemnify any broker-dealer
        that
        participates in transactions involving the sale of the shares against certain
        liabilities, including liabilities arising under the Securities
        Act.

       

      We
        have
        agreed to indemnify the selling stockholders against liabilities, including
        liabilities under the Securities Act and state securities laws, relating
        to the
        registration of the shares offered by this prospectus.

       

      We
        have
        agreed with the selling stockholders to keep the registration statement of
        which
        this prospectus constitutes a part effective until the earlier of (1) such
        time
        as all of the shares covered by this prospectus have been disposed of pursuant
        to and in accordance with the registration statement or (2) the date on which
        the shares may be sold pursuant to Rule 144(k) of the Securities
        Act.

      
        
          
          

        

        
          19

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        B

       

      [____________
        __, 20__]

       

      [Transfer
        Agent]

       

      Re: a21,
        Inc.
        Registration Statement on Form [SB-2]

       

      Ladies
        and Gentlemen:

       

      As
        counsel to a21, Inc., a Texas corporation (the “Company”), we have been
        requested to provide instructions to you in connection with the resale by
        the
        individuals or entitles listed on Schedule A attached hereto (the “Selling
        Stockholders”), of an aggregate of [amount] shares (the “Shares”) of the
        Company’s Common Stock.

       

      A
        Registration Statement on Form SB-2 under the Securities Act of 1933, as
        amended
        (the “Act”), with respect to the resale of the Shares was declared effective by
        the Securities and Exchange Commission on [date]. Enclosed is the Prospectus
        dated [date]. We understand that the Shares are to be offered and sold in
        the
        manner described in the Prospectus.

       

      Based
        upon the foregoing, provided that the Selling Stockholder represents in writing
        to you that the Shares owned by such Selling Stockholder were sold in accordance
        with the terms of the Prospectus and that such Selling Stockholder complied
        with
        the prospectus delivery requirements under the Act, upon request by the Selling
        Stockholders at any time while the registration statement remains effective,
        it
        is our opinion that the Shares have been registered for resale under the
        Act and
        new certificates evidencing the Shares upon their transfer or re-registration
        by
        the Selling Stockholders may be issued without restrictive legend. The Company
        will advise you if the registration statement is not available or effective
        at
        any point in the future.

       

      Very
        truly yours,

       

      [Company
        counsel]

      
        
          
          

        

        
          20

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        C

       

      Securities
        Permitted to be Registered

      

        
          	
                  Category

                	 	
                  Shareholder

                	 	
                  Common

                	 	
                  Warrants

                	 	
                  Preferred

                	 	
                  Totals

                	 
	
                  Feb
                    04 SuperStock Seller

                	 	
                   

                	
                  C.
                    Donald Wiggins 

                	 	 	
                  50,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 SuperStock Seller

                	 	 	
                  James
                    Ong 

                	 	 	
                  287,889

                	 	 	
                  43,988

                	 	 	
                  2,336,874

                	 	 	 	 
	
                  Feb
                    04 SuperStock Seller

                	 	 	
                  Kai
                    Y. Chiang

                	 	 	
                  7,464

                	 	 	
                  1,140

                	 	 	
                  60,591

                	 	 	 	 
	
                  Feb
                    04 SuperStock Seller

                	 	 	
                  Richard
                    Ong 

                	 	 	
                  114,118

                	 	 	
                  17,436

                	 	 	
                  926,331

                	 	 	 	 
	
                  Feb
                    04 SuperStock Seller

                	 	 	
                  Susan
                    O. Chiang 

                	 	 	
                  114,118

                	 	 	
                  17,436

                	 	 	
                  926,331

                	 	 	 	 
	
                  Feb
                    04 SuperStock Seller

                	 	 	
                  William
                    F. Beermann Living Trust 

                	 	 	
                  -

                	 	 	
                  80,000

                	 	 	
                  750,024

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  5,733,740

                	 
	
                  Feb
                    04 Equity

                	 	 	
                  Glossy
                    Finish, LLC 

                	 	 	
                  175,000

                	 	 	
                  246,330

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Equity

                	 	 	
                  LCA
                    Capital Partners I, Inc. 

                	 	 	
                  2,922,000

                	 	 	
                  3,368,100

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Equity

                	 	 	
                  Thomas
                    V. Butta 

                	 	 	
                  125,000

                	 	 	
                  175,950

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Equity

                	 	 	
                  Whitney
                    Holdings, Inc. 

                	 	 	
                  450,000

                	 	 	
                  633,420

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  8,095,800

                	 
	
                  Feb
                    04 Unsecured Notes

                	 	 	
                  Lewis
                    C. Pell 

                	 	 	
                  -

                	 	 	
                  90,000

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Unsecured Notes

                	 	 	
                  Michael
                    Morris

                	 	 	
                  -

                	 	 	
                  37,800

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Unsecured Notes

                	 	 	
                  Richard
                    Neslund 

                	 	 	
                  -

                	 	 	
                  135,000

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Unsecured Notes

                	 	 	
                  Vertical
                    Capital Partners, Inc. 

                	 	 	
                  -

                	 	 	
                  25,200

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    04 Unsecured Notes

                	 	 	
                  Vestal
                    Venture Capital 

                	 	 	
                  -

                	 	 	
                  720,000

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  1,008,000

                	 
	
                  Feb
                    05 Senior Notes

                	 	 	
                  Cohanzick
                    Credit Opportunities Master Fund Ltd.

                	 	 	
                  -

                	 	 	
                  425,000

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    05 Senior Notes

                	 	 	
                  Gabriel
                    Capital L.P. 

                	 	 	
                  -

                	 	 	
                  425,000

                	 	 	
                  -

                	 	 	 	 
	
                  Feb
                    05 Senior Notes

                	 	 	
                  John
                    L. Steffens 

                	 	 	
                  -

                	 	 	
                  212,500

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  1,062,500

                	 
	
                  May
                    05 Grant

                	 	 	
                  Thomas
                    V. Butta

                	 	 	
                  1,200,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  May
                    05 Grant

                	 	 	
                  Albert
                    H. Pleus

                	 	 	
                  960,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  May
                    05 Grant

                	 	 	
                  Haim
                    Ariav

                	 	 	
                  250,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  October
                    05 Grant

                	 	 	
                  Susan
                    Chiang

                	 	 	
                  175,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  June
                    05 Grant

                	 	 	
                  Ardell
                    D. Albers

                	 	 	
                  95,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  May
                    05 Grant

                	 	 	
                  Luke
                    A. Allen

                	 	 	
                  140,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  May
                    05 Grant

                	 	 	
                  Vincent
                    C. Butta

                	 	 	
                  110,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 

        

        
          
            
            

          

          
            21

            
              

            

          

          
            
            

          

        

         

        
          	
                  Category

                	 	
                  Shareholder

                	 	
                  Common

                	 	
                  Warrants

                	 	
                  Preferred

                	 	
                  Totals

                

        

        
          	
                  May
                    05 Grant

                	 	 	
                  Philip
                    N. Garfinkle

                	 	 	
                  140,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  May
                    05 Grant

                	 	 	
                  C.
                    Donald Wiggins

                	 	 	
                  120,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  3,190,000

                	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Ahab
                    International, Limited 

                	 	 	
                  11,110,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Ahab
                    Partners, L.P.

                	 	 	
                  9,090,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  CRT
                    Capital Group, LLC 

                	 	 	
                  3,845,000

                	 	 	 	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  John
                    L. Steffens 

                	 	 	
                  2,000,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Kevin
                    Murphy

                	 	 	
                  244,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  La
                    Grange Capital Partners Offshore Fund, Ltd. 

                	 	 	
                  494,664

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  La
                    Grange Capital Partners, L.P. 

                	 	 	
                  2,005,336

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Mikhail
                    Lapushner 

                	 	 	
                  650,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Mojo
                    Management, LLC 

                	 	 	
                  875,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Ray
                    and Amy Rivers 

                	 	 	
                  1,000,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  StarVest
                    Partners, L.P. 

                	 	 	
                  12,500,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Sept/Oct
                    05 Financing

                	 	 	
                  Steve
                    Mazur 

                	 	 	
                  500,000

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  44,314,000

                	 
	
                  Oct
                    04 Ingram Seller

                	 	 	
                  Clonure
                    Limited

                	 	 	
                  4,479,721

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Oct
                    04 Ingram Seller

                	 	 	
                  Louis
                    & Ruth Ingram

                	 	 	
                  1,357,491

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	
                  Oct
                    04 Ingram Seller

                	 	 	
                  David
                    Jeffrey

                	 	 	
                  305,436

                	 	 	
                  -

                	 	 	
                  -

                	 	 	 	 
	 	 	 	
                   

                	 	 	 	 	 	 	 	 	 	 	 	
                  6,142,648

                	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
                  Totals:

                	 	 	 	 	 	
                  57,892,237

                	 	 	
                  6,654,300

                	 	 	
                  5,000,151

                	 	 	
                  69,546,688

                	 

        

      

       

      
        
          
          

        

        
          22SECURITIES
        PURCHASE AGREEMENT

       

      THE
        PURCHASERS OF THE NOTES NAMED HEREIN

      QUEEQUEG
        PARTNERS, L.P., as Agent

       

      a21,
        INC.

      and
        SUPERSTOCK, INC.

       

      Dated:
        April 27, 2006

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      
        	
                1.

              	
                Agreement
                  to Sell and Purchase

              	
                3

              
	 	 	 
	
                2.

              	
                Fees

              	
                3

              
	 	 	 
	
                3.

              	
                Closing,
                  Delivery and Payment

              	
                3

              
	 	 	 
	
                 

              	
                
                  3.1    Closing

                

              	
                3

              
	 	 	 
	
                 

              	
                
                  3.2    Delivery

                

              	
                4

              
	 	 	 
	
                4.

              	
                Representations
                  and Warranties of the Company

              	
                4

              
	 	 	 
	
                 

              	
                
                  4.1    Organization,
                    Good Standing and Qualification

                

              	
                5

              
	 	 	 
	
                 

              	
                
                  4.2    Subsidiaries

                

              	
                5

              
	 	 	 
	
                 

              	
                
                  4.3    Capitalization;
                    Voting Rights

                

              	
                5

              
	 	 	 
	
                 

              	
                
                  4.4    Authorization;
                    Binding Obligations

                

              	
                7

              
	 	 	 
	
                 

              	
                
                  4.5    Liabilities

                

              	
                7

              
	 	 	 
	
                 

              	
                
                  4.6    Financial
                    Statements

                

              	
                8

              
	 	 	 
	
                 

              	
                
                  4.7    Agreements

                

              	
                8

              
	 	 	 
	
                 

              	
                
                  4.8    Obligations
                    to Related Parties

                

              	
                8

              
	 	 	 
	
                 

              	
                
                  4.9    Changes

                

              	
                8

              
	 	 	 
	
                 

              	
                
                  4.10  
                    Title to Properties and Assets; Encumbrances,
                    Etc

                

              	
                10

              
	 	 	 
	
                 

              	
                
                  4.11    Intellectual
                    Property

                

              	
                10

              
	 	 	 
	
                 

              	
                
                  4.12    Compliance
                    with Other Instruments; No Conflict, Breach Violation or
                    Default

                

              	
                12

              
	 	 	 
	
                 

              	
                
                  4.13    Litigation

                

              	
                12

              
	 	 	 
	
                 

              	
                
                  4.14    Consents

                

              	
                12

              
	 	 	 
	
                 

              	
                
                  4.15    Tax
                    Returns and Payments

                

              	
                13

              
	 	 	 
	
                 

              	
                
                  4.16    Employees.

                

              	
                13

              
	 	 	 
	
                 

              	
                
                  4.17    Registration
                    Rights and Voting Rights

                

              	
                14

              
	 	 	 
	
                 

              	
                
                  4.18    Compliance
                    with Laws; Permits

                

              	
                14

              
	 	 	 
	
                 

              	
                
                  4.19    Environmental
                    Matters

                

              	
                15

              
	 	 	 
	
                 

              	
                
                  4.20    Insurance
                    Coverage

                

              	
                15

              
	 	 	 
	
                 

              	
                
                  4.21    Valid
                    Offering

                

              	
                15

              
	 	 	 
	
                 

              	
                
                  4.22    SEC
                    Reports

                

              	
                15

              
	 	 	 
	
                 

              	
                
                  4.23    a21’s
                    Listing

                

              	
                16

              
	 	 	 
	
                 

              	
                
                  4.24    Brokers
                    and Finders

                

              	
                16

              
	 	 	 
	
                 

              	
                
                  4.25    No
                    Directed Selling Efforts or General Solicitation

                

              	
                16

              
	 	 	 
	
                 

              	
                
                  4.26    No
                    Integrated Offering

                

              	
                16

              
	 	 	 
	
                 

              	
                
                  4.27    Questionable
                    Payments

                

              	
                16

              
	 	 	 
	
                 

              	
                
                  4.28    Internal
                    Controls

                

              	
                17

              
	 	 	 
	
                 

              	
                
                  4.29    Stop
                    Transfer

                

              	
                17

              
	 	 	 
	
                 

              	
                
                  4.30    Dilution

                

              	
                17

              
	 	 	 
	
                 

              	
                
                  4.31    Disclosures

                

              	
                17

              
	 	 	 
	
                5.

              	
                Representations
                  and Warranties of the Purchasers

              	
                18

              
	 	 	 
	
                 

              	
                
                  5.1    No
                    Shorting

                

              	
                18

              
	 	 	 
	
                 

              	
                
                  5.2    Requisite
                    Power and Authority

                

              	
                18

              
	 	 	 
	
                 

              	
                
                  5.3    Investment
                    Representations

                

              	
                18

              
	 	 	 
	
                 

              	
                
                  5.4    Such
                    Purchaser Bears Economic Risk

                

              	
                18

              
	 	 	 
	
                 

              	
                
                  5.5    Acquisition
                    for Own Account

                

              	
                19

              

      

      
        
          
          

        

        
          i

          
            

          

        

        
          
          

        

      

      

      
        	
                 

              	
                
                  5.6    Such
                    Purchaser Can Protect Its Interest

                

              	
                19

              
	 	 	 
	
                 

              	
                
                  5.7    Accredited
                    Investor

                

              	
                19

              
	 	 	 
	
                 

              	
                
                  5.8    Legends

                

              	
                19

              
	 	 	 
	
                6.

              	
                Covenants
                  of the Company

              	
                20

              
	 	 	 
	
                 

              	
                
                  6.1    Reservation
                    of Common Stock; Increase of Authorized Capital

                

              	
                20

              
	 	 	 
	
                 

              	
                
                  6.2    Stop-Orders

                

              	
                20

              
	 	 	 
	
                 

              	
                
                  6.3    Listing

                

              	
                20

              
	 	 	 
	
                 

              	
                
                  6.4    Market
                    Regulations

                

              	
                20

              
	 	 	 
	
                 

              	
                
                  6.5    Reporting
                    Requirements

                

              	
                21

              
	 	 	 
	
                 

              	
                
                  6.6    Use
                    of Funds

                

              	
                22

              
	 	 	 
	
                 

              	
                
                  6.7    Access
                    to Facilities

                

              	
                22

              
	 	 	 
	
                 

              	
                
                  6.8    Conduct
                    of Business

                

              	
                22

              
	 	 	 
	
                 

              	
                
                  6.9    Change
                    of Business; Misstatements

                

              	
                23

              
	 	 	 
	
                 

              	
                
                  6.10   Notice
                    of Event of Default

                

              	
                23

              
	 	 	 
	
                 

              	
                
                  6.11   Suits
                    and Proceedings

                

              	
                23

              
	 	 	 
	
                 

              	
                
                  6.12   Material
                    Breach of Contract

                

              	
                23

              
	 	 	 
	
                 

              	
                
                  6.13   Officer’s
                    Certificate

                

              	
                23

              
	 	 	 
	
                 

              	
                
                  6.14   Taxes

                

              	
                24

              
	 	 	 
	
                 

              	
                
                  6.15   Intellectual
                    Property

                

              	
                24

              
	 	 	 
	
                 

              	
                
                  6.16   Properties

                

              	
                24

              
	 	 	 
	
                 

              	
                
                  6.17   No
                    Conflicting Agreements

                

              	
                24

              
	 	 	 
	
                 

              	
                
                  6.18   Insurance

                

              	
                24

              
	 	 	 
	
                 

              	
                
                  6.19   Compliance
                    with Laws

                

              	
                25

              
	 	 	 
	
                 

              	
                
                  6.20   Removal
                    of Legends

                

              	
                25

              
	 	 	 
	
                 

              	
                
                  6.21   Director
                    Designee

                

              	
                25

              
	 	 	 
	
                 

              	
                
                  6.22   Required
                    Approvals

                

              	
                26

              
	 	 	 
	
                 

              	
                
                  6.23   Margin
                    Stock

                

              	
                29

              
	 	 	 
	
                 

              	
                
                  6.24   Option
                    to Participate in Future Financings

                

              	
                30

              
	 	
              	 
	 	6.25   Form
                D; Blue Sky Filings	30
	 	 	 
	
                7.

              	
                Covenants
                  of the Purchasers

              	
                31

              
	 	 	 
	
                 

              	
                
                  7.1   Confidentiality

                

              	
                31

              
	 	 	 
	
                 

              	
                
                  7.2    Non-Public
                    Information

                

              	
                31

              
	 	 	 
	
                 

              	
                
                  7.3    Share
                    Increase

                

              	
                31

              
	 	 	 
	
                 

              	
                
                  7.4    Tax
                    Information

                

              	
                31

              
	 	 	 
	
                8.

              	
                Indemnification

              	
                32

              
	 	 	 
	
                 

              	
                
                  8.1    Company
                    Indemnification

                

              	
                32

              
	 	 	 
	
                 

              	
                
                  8.2    Conduct
                    of Indemnification Proceedings

                

              	
                32

              
	 	 	 
	
                9.

              	
                Miscellaneous

              	
                33

              
	 	 	 
	
                 

              	
                
                  9.1    Governing
                    Law, Jurisdiction and Waiver of Jury Trial

                

              	
                33

              
	 	 	 
	
                 

              	
                
                  9.2    Severability

                

              	
                33

              
	 	 	 
	
                 

              	
                
                  9.3    Survival

                

              	
                34

              
	 	 	 
	
                 

              	
                
                  9.4    Successors

                

              	
                34

              
	 	 	 
	
                 

              	
                
                  9.5    Amendment
                    and Waiver

                

              	
                34

              
	 	 	 
	
                 

              	
                
                  9.6    Notices

                

              	
                34

              
	 	 	 
	
                 

              	
                
                  9.7    Titles
                    and Subtitles

                

              	
                35

              

      

      
        
          
          

        

        
          ii

          
            

          

        

        
          
          

        

      

      

      
        	
                 

              	
                
                  9.8    Facsimile
                    Signatures; Counterparts

                

              	
                35

              
	 	 	 
	
                 

              	
                
                  9.9    Broker’s
                    Fees

                

              	
                35

              
	 	 	 
	
                 

              	
                
                  9.10   Construction

                

              	
                36

              
	 	 	 
	
                 

              	
                
                  9.11   Termination

                

              	
                36

              
	 	 	 
	
                 

              	
                
                  9.12   Appointment
                    of Agent

                

              	
                36

              
	 	 	 
	
                 

              	
                
                  9.13   Duties
                    of Agent

                

              	
                36

              
	 	 	 
	
                 

              	
                
                  9.14   Application
                    of Proceeds

                

              	
                37

              
	 	 	 
	
                 

              	
                
                  9.15   Actions
                    in Concert

                

              	
                38

              
	 	 	 
	
                 

              	
                
                  9.16   Agent’s
                    Indemnity

                

              	
                38

              
	 	 	 
	
                 

              	
                
                  9.17   Agent
                    and Affiliates

                

              	
                39

              
	 	 	 
	
                 

              	
                
                  9.18   Purchaser
                    Decisions

                

              	
                39

              
	 	 	 
	
                 

              	
                
                  9.19   Confidential
                    Information

                

              	
                39

              
	 	 	 
	
                 

              	
                
                  9.20   Publicity

                

              	
                40

              
	 	 	 
	
                 

              	
                
                  9.21   Expenses

                

              	
                41

              
	 	 	 
	
                 

              	
                
                  9.22   Independent
                    Nature of Purchasers' Obligations and Rights

                

              	
                41

              
	 	
              	 
	 	
                9.23    
                  Equal Treatment of Purchasers

              	41

      

       

      
        
          
          

        

        
          iii

          
            

          

        

        
          
          

        

      

       

      
        	
                LIST
                  OF EXHIBITS

              	 
	
                List
                  of Purchasers

              	
                Exhibit
                  A

              
	
                Form
                  of Convertible Term Note

              	
                Exhibit
                  B

              
	
                Form
                  of Future Note

              	
                Exhibit
                  C

              
	
                 

                LIST
                  OF SCHEDULES

                 

              	 
	
                Subsidiaries

              	
                Schedule
                  4.2

              
	
                Capitalization

              	
                Schedule
                  4.3

              
	
                Agreements

              	
                Schedule
                  4.7

              
	
                Obligations
                  to Related Parties

              	
                Schedule
                  4.8

              
	
                Changes

              	
                Schedule
                  4.9

              
	
                Title
                  to Properties

              	
                Schedule
                  4.10

              
	
                Litigation

              	
                Schedule
                  4.13

              
	
                Tax
                  Returns and Payments

              	
                Schedule
                  4.15

              
	
                Employees

              	
                Schedule
                  4.16

              
	
                Registration
                  Rights and Voting Rights

              	
                Schedule
                  4.17

              
	
                SEC
                  Reports

              	
                Schedule
                  4.22

              
	
                Internal
                  Controls

              	
                Schedule
                  4.28

              
	
                Indebtedness

              	
                Schedule
                  6.10(d)

              

      

       

      
        
          
          

        

        
          1

          
            

          

        

        
          
          

        

      

       

      SECURITIES
        PURCHASE AGREEMENT

       

      THIS
        SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of
        April 27, 2006, by and among a21, Inc., a Texas corporation (“a21”), and
        Superstock, Inc., a Florida corporation (“Superstock” and, together with a21,
        individually, and collectively, the “Company”), the purchasers set forth on
Exhibit
        A
        hereto
        (each an “Initial Purchaser” and collectively, the “Initial Purchasers”),
        purchasers that hereinafter become a party hereto in accordance with the
        terms
        of a joinder agreement on terms and conditions reasonably acceptable to the
        Company and the Initial Purchasers (as defined herein) (each a “Future
        Purchaser” and, collectively, the “Future Purchasers” and together with the
        Initial Purchasers, collectively, the “Purchasers”) and Queequeg Partners, L.P.,
        as agent for itself and the Other Purchasers (the “Agent”).

       

      RECITALS

       

      WHEREAS,
        the Company has authorized the sale to the Initial Purchasers
        of
        Secured Convertible Term Notes, which are the joint and several obligations
        of
        a21 and Superstock, in the aggregate principal amount of Fifteen Million
        Five
        Hundred Thousand Dollars ($15,500,000) in the form of Exhibit B
        hereto
        (as amended, modified and/or supplemented from time to time, each an “Initial
        Note” and collectively, the “Initial Notes”), which Initial Notes are
        convertible into shares (the “Conversion Shares”) of a21’s common stock, $0.001
        par value per share (the “Common Stock”), at an initial conversion price of
        $0.65 per share of Common Stock (the “Initial Conversion Price”);

       

      WHEREAS,
        the Company has authorized the sale to the Future Purchasers of Secured
        Convertible Notes in the aggregate principal amount of Five Hundred Thousand
        Dollars ($500,000) in the form of Exhibit C (as amended, restated, modified
        and/or supplemented from time to time, each a “Future Note” and collectively,
        the “Future Notes”), provided that the sale of such Future Notes shall be
        consummated on or before May 31, 2006 (provided that the Agent, by written
        consent, may extend such date until June 30, 2006 in its sole discretion)
        and
        the terms of such Future Notes shall be in a form substantially similar to
        the
        Initial Notes;

       

      WHEREAS,
        each Purchaser desires to purchase an Initial Note or a Future Note (a “Note”)
        on the terms and conditions set forth herein;

       

      WHEREAS,
        the Company and the Purchasers are executing and delivering this Agreement
        in
        reliance upon the exemption from securities registration afforded by the
        provisions of Regulation D (“Regulation D”), as promulgated by the U.S.
        Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933,
        as amended (the “Securities Act”);

       

      WHEREAS,
        contemporaneous with the sale of the Notes, the parties hereto will execute
        and
        deliver a Registration Rights Agreement, in the form attached hereto as Exhibit
        D (the “Registration Rights Agreement”), pursuant to which the Company will
        agree to provide certain registration rights under the Securities Act and
        the
        rules and regulations promulgated thereunder, and applicable state securities
        laws; and

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      WHEREAS,
        the Company desires to issue and sell the Notes to the Purchasers on the
        terms
        and conditions set forth herein.

       

      NOW,
        THEREFORE, in consideration of the foregoing recitals and the mutual promises,
        representations, warranties and covenants hereinafter set forth and for other
        good and valuable consideration, the receipt and sufficiency of which are
        hereby
        acknowledged, the parties hereto agree as follows:

       

      1. Agreement
        to Sell and Purchase.
        Pursuant to the terms and conditions set forth in this Agreement, on the
        Closing
        Date (as defined in Section 3), the Company shall sell to the Initial
        Purchasers, and the Initial Purchasers shall purchase from the Company, the
        Initial Notes. The sale of the Initial Notes on the Closing Date shall be
        known
        as the “Initial Offering.” The Future Notes may be sold to the Future Purchasers
        at any time after the Closing Date; provided that the sale of such Future
        Notes
        shall be consummated on or before May 31, 2006 (or upon the prior written
        consent of Agent, June 30, 2006). The sale of the Future Notes shall be known
        as
        a “Follow On Offering”). The Notes will mature on the Maturity Date (as defined
        in the Initial Notes). Collectively, the Notes and Common Stock issuable
        upon
        conversion of the Notes are referred to as the “Securities.”

       

      2. Fees.
        On the
        Closing Date:

       

      (a) Subject
        to limitation below, the Company shall reimburse the Initial Purchasers for
        their reasonable expenses (including legal fees and expenses) incurred in
        connection with the preparation and negotiation of this Agreement and the
        Related Agreements (as hereinafter defined), and expenses incurred in connection
        with the Initial Purchasers’ due diligence review of the Company and its
        Subsidiaries (as defined in Section 4.2) and all related matters. Amounts
        required to be paid under this Section 2(a) will be due and payable on the
        Closing Date and shall be no greater than $65,000 in the aggregate for all
        such
        expenses, incurred by all Initial Purchasers, referred to in this Section
        2(a).

       

      (b) The
        expenses referred to in the preceding clause (a) shall be due and payable
        at the
        closing of the Initial Offering.

       

      3. Closing,
        Delivery and Payment.

       

      3.1 Closing.
        Subject
        to the terms and conditions herein, (a) the closing of the Initial Offering
        (the
“Closing”), shall take place on the date hereof, at such time or place as the
        Company and the Initial Purchasers may mutually agree (such date is hereinafter
        referred to as the “Closing Date”) and (b) the closing of a Follow On Offering
        shall take place, subject to the limitations set forth in Section 1 hereof,
        on a
        date, at such time or place as the Company and the applicable Future Purchasers
        may mutually agree.

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      
                            3.2
Delivery.

         

      

      (a) At
        the
        Initial Closing and on the closing of a Follow On Offering, the Company will
        deliver to the applicable Purchasers, among other things,

       

      (i) the
        applicable Note duly executed by the Company;

       

      (ii) the
        Registration Rights Agreement duly executed by a21;

       

      (iii) the
        Master Security Agreement dated as of the date hereof among the Company,
        certain
        Subsidiaries of the Company and the Agent (as amended, modified and/or
        supplemented from time to time, the “Master Security Agreement”) duly executed
        by the Company;

       

      (iv) the
        Deed
        of Charge Over Shares dated as of the date hereof between Superstock and
        the
        Agent (as amended, modified and/or supplemented from time to time, the “Stock
        Pledge Agreement”);

       

      (v) a
        Certificate, executed on behalf of each Company by its Secretary, dated as
        of
        the Closing Date, certifying the resolutions adopted by the Board of Directors
        of such Company approving the transactions contemplated by this Agreement
        and
        the other Related Agreements and the issuance of the Securities, certifying
        the
        current versions of the Charter and Bylaws of the Company and certifying
        as to
        the signatures and authority of persons signing the Related Agreements and
        related documents on behalf of the Company; and

       

      (vi) an
        opinion from Loeb & Loeb LLP, the Company's counsel, dated as of the Closing
        Date, in form and substance reasonably acceptable to the Purchasers and
        addressing such legal matters as the Purchasers may reasonably
        request.

       

      (b) At
        the
        Initial Closing and on the closing of a Follow On Offering, the applicable
        Purchasers will deliver to the Company the amounts set forth in the applicable
        Notes by certified funds or wire transfer.

       

      4. Representations
        and Warranties of the Company.
        The
        Company, as of the Closing Date, hereby represents and warrants to the
        Purchasers as follows

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

       

      4.1 Organization,
        Good Standing and Qualification.
        Each of
        the Company and each of its Subsidiaries is a corporation, partnership, company
        or limited liability company, as the case may be, duly organized and validly
        existing under the laws of its jurisdiction of organization. Each of the
        Company
        and each of its Subsidiaries has the corporate, limited liability company
        or
        partnership, as the case may be, power and authority to operate its business
        and
        to own and operate its properties and assets and, insofar as it is or shall
        be a
        party thereto, to (1) execute and deliver (i) this Agreement, (ii) the Notes,
        (iii) the Master Security Agreement, (iv) the Registration Rights Agreement,
        (v)
        the Stock Pledge Agreement and (vi) all other documents, instruments and
        agreements entered into in connection with the transactions contemplated
        hereby
        and thereby (the preceding clauses (ii) through (v), collectively, the “Related
        Agreements”); (2) issue and sell the Notes and, as respects a21, the Conversion
        Shares; and (3) carry out the provisions of this Agreement and the Related
        Agreements and to carry on its business as presently conducted. Each of the
        Company and each of its Subsidiaries is duly qualified and is authorized
        to do
        business and is in good standing as a foreign corporation, partnership or
        limited liability company, as the case may be, in all jurisdictions in which
        the
        nature or location of its activities and of its properties (both owned and
        leased) makes such qualification necessary, except for those jurisdictions
        in
        which failure to do so has not, or could not reasonably be expected to have,
        individually or in the aggregate, a material adverse effect on the business,
        assets, liabilities or financial condition of the Company and its Subsidiaries,
        taken as a whole (a “Material Adverse Effect”).

       

      4.2 Subsidiaries.
        Each
        direct and indirect Subsidiary of the Company, the direct owner of such
        Subsidiary and its percentage ownership thereof, is set forth on Schedule
        4.2.
        For the
        purpose of this Agreement, a “Subsidiary” of any person or entity means (i) a
        corporation or other entity whose shares of stock or other ownership interests
        having ordinary voting power (other than stock or other ownership interests
        having such power only by reason of the happening of a contingency) to elect
        a
        majority of the directors of such corporation, or other persons or entities
        performing similar functions for such person or entity, are owned, directly
        or
        indirectly, by such person or entity or (ii) a corporation or other entity
        in
        which such person or entity owns, directly or indirectly, more than 50% of
        the
        equity interests at such time.

       

      4.3 Capitalization;
        Voting Rights.

       

      (a) The
        authorized capital stock of a21, as of the date hereof consists of 100,100,000
        shares, of which 100,000,000 are shares of Common Stock, par value $0.001
        per
        share, 77,073,479 shares of which are issued and outstanding as of March
        30,
        2006, and 100,000 are shares of preferred stock, par value $0.001 per share
        of
        which 14,480 shares of preferred stock are issued and outstanding. The
        authorized, issued and outstanding capital stock of each Subsidiary of the
        Company is set forth on Schedule
        4.3.

      
        
          
          

        

        
          5

          
            

          

        

        
          
          

        

      

       

      (b) Except
        as
        disclosed on Schedule
        4.3,
        other
        than: (i) the shares reserved for issuance under a21’s stock option plans; and
        (ii) shares which may be granted pursuant to this Agreement and the Related
        Agreements, there are no outstanding options, warrants, rights (including
        conversion or preemptive rights and rights of first refusal), proxy or
        stockholder agreements, or arrangements or agreements of any kind for the
        purchase or acquisition from a21 of any of its securities. Except as disclosed
        on Schedule
        4.3,
        neither
        the offer, issuance or sale of any of the Notes, or the issuance of any of
        the
        Conversion Shares, nor the consummation of any transaction contemplated hereby
        will result in a change in the price or number of any securities of a21
        outstanding, under anti-dilution or other similar provisions contained in
        or
        affecting any such securities.

       

      (c) All
        issued and outstanding shares of a21’s capital stock: (i) have been duly
        authorized and validly issued and are fully paid and nonassessable and free
        of
        preemptive rights; and (ii) were issued in compliance with all applicable
        state
        and federal laws concerning the issuance of securities and any rights of
        third
        parties. Except as described on Schedule
        4.3
        or
        disclosed in the Exchange Act Filings (as defined herein), all of the issued
        and
        outstanding shares of capital stock of each Subsidiary have been duly authorized
        and validly issued and are fully paid, nonassessable and free of pre-emptive
        rights, were issued in full compliance with applicable state and federal
        securities law and any rights of third parties and are owned by the Company,
        beneficially and of record, subject to no Encumbrance (as defined below).
        Except
        as described on Schedule
        4.3
        or
        disclosed in the Exchange Act Filings, no Person is entitled to pre-emptive
        or
        similar statutory or contractual rights with respect to any securities of
        the
        Company. Except as contemplated by this Agreement, neither the Company nor
        any
        of its Subsidiaries is currently in negotiations for the issuance of any
        equity
        securities of any kind other than Shares to be issued under stock option
        plans.
        Except as described on Schedule
        4.3
        or
        disclosed in the Exchange Act Filings, and except for the Registration Rights
        Agreement, there are no voting agreements, buy-sell agreements, option or
        right
        of first purchase agreements or other agreements of any kind among the Company
        and any of the securityholders of the Company relating to the securities
        of the
        Company held by them.

       

      (d) Except
        as
        described on Schedule
        4.3
        or
        disclosed in the Exchange Act Filings, the Company does not have outstanding
        stockholder purchase rights or “poison pill” or any similar arrangement in
        effect giving any person or entity the right to purchase any equity interest
        in
        the Company upon the occurrence of certain events.

       

      (e) The
        rights, preferences, privileges and restrictions of the shares of the Common
        Stock are as stated in a21’s Certificate of Incorporation (the “Charter”). When
        issued in compliance with the provisions of this Agreement and a21’s Charter,
        the Securities will be validly issued, fully paid and nonassessable, and
        will be
        free of any Encumbrances; provided, however, that the Securities may be subject
        to restrictions on transfer under state and/or federal securities laws as
        set
        forth herein or as otherwise required by such laws at the time a transfer
        is
        proposed.

      
        
          
          

        

        
          6

          
            

          

        

        
          
          

        

      

       

      (f) Other
        than for a21 receiving the consent of the requisite number of its shareholders
        under applicable law to increase the number of its authorized shares, notifying
        all of its shareholders, under and in accordance with applicable state and
        federal securities laws of such increase in the number of its authorized
        shares
        and filing its charter or amendment to its charter with its state of formation
        to reflect such increase and such other documents as may be required under
        applicable law to effectuate such increase (such consent, notification and
        filing, the “Share Increase”), the Conversion Shares have been duly and validly
        authorized and, when issued upon the due conversion of the Notes, will be
        validly issued, fully paid and nonassessable, and shall be free and clear
        of all
        encumbrances and restrictions (other than those created by the Purchasers),
        except for restrictions on transfer set forth in the Related Agreements or
        imposed by applicable securities laws. Subject to the filing of the Certificate
        of Incorporation of a21 in the State of Delaware for the reincorporation
        of a21
        in the State of Delaware and the Share Increase, the Company has reserved
        a
        sufficient number of shares of Common Stock for issuance upon the conversion
        of
        the Notes, free and clear of all encumbrances and restrictions, except for
        restrictions on transfer set forth in the Related Agreements or imposed by
        applicable securities laws and except for those created by the
        Purchasers.

       

      4.4 Authorization;
        Binding Obligations.
        All
        corporate, partnership or limited liability company, as the case may be,
        action
        on the part of the Company and each of its Subsidiaries (including their
        respective officers, directors and stockholders) necessary for the authorization
        of this Agreement and the Related Agreements, the performance of all obligations
        of the Company and its Subsidiaries hereunder and under the other Related
        Agreements at the Closing and, the authorization, sale, issuance and delivery
        of
        the Note has been taken or will be taken prior to the Closing. This Agreement
        and the Related Agreements, when executed and delivered and to the extent
        it is
        a party thereto, will be valid and binding obligations of each of the Company
        and each of its Subsidiaries, enforceable against each such person or entity
        in
        accordance with their terms, except:

       

      (a) as
        limited by applicable bankruptcy, insolvency, reorganization, moratorium
        or
        other laws of general application affecting enforcement of creditors’ rights;
        and

       

      (b) general
        principles of equity that restrict the availability of equitable or legal
        remedies.

       

      The
        sale
        of the Notes and the subsequent conversion of the Notes into Conversion Shares
        are not and will not be subject to any preemptive rights or rights of first
        refusal that have not been properly waived or complied with.

       

      4.5 Liabilities.
        As of
        the Closing Date, neither the Company nor any of its Subsidiaries has any
        material liabilities, contingent or otherwise, except current liabilities
        incurred in the ordinary course of business, consistent (as to amount and
        nature) with past practices, and liabilities disclosed in any of the Company’s
        filings under the Securities Exchange Act of 1934 (“Exchange Act”) made prior to
        the date of this Agreement but after January 1, 2005 (collectively, the
“Exchange Act Filings”), copies of which have been made available to the
        Purchasers.

      
        
          
          

        

        
          7

          
            

          

        

        
          
          

        

      

       

      4.6 Financial
        Statements.
        The
        financial statements included in each Exchange Act Filing present fairly,
        in all
        material respects, the consolidated financial position of the Company as
        of the
        dates shown and its consolidated results of operations and cash flows for
        the
        periods shown, and such financial statements have been prepared in conformity
        with United States generally accepted accounting principles applied on a
        consistent basis (“GAAP”) (except as may be disclosed therein or in the notes
        thereto, and, in the case of quarterly financial statements, as permitted
        by
        Form 10-QSB under the Exchange Act).

       

      4.7 Agreements.
        Except
        as set forth on Schedule
        4.7
        or as
        disclosed in any Exchange Act Filings, there are no agreements, understandings,
        instruments, contracts, proposed transactions, judgments, orders, writs or
        decrees to which the Company or any of its Subsidiaries is a party or by
        which
        it is bound which may involve obligations (contingent or otherwise) of, or
        payments to, the Company or any of its Subsidiaries in excess of $175,000
        (other
        than obligations of, or payments to, the Company or any of its Subsidiaries
        arising from agreements entered into in the ordinary course of
        business).

       

      4.8 Obligations
        to Related Parties.
        Except
        as disclosed in the Exchange Act Filings or as disclosed on Schedule
        4.8,
        none of
        the officers or directors of the Company and, to the Company’s knowledge, none
        of the employees of the Company is presently a party to any transaction with
        the
        Company or any Subsidiary, including any contract, agreement or other
        arrangement providing for the furnishing of services to or by, providing
        for
        rental of real or personal property to or from, or otherwise requiring payments
        to or from any officer, director or such employee or, to the Company’s
        knowledge, any entity in which any officer, director, or any such employee
        has a
        substantial interest or is an officer, director, trustee or partner, other
        than:

       

      (a) for
        payment of salary for services rendered and for bonus payments made in the
        ordinary course of business, consistent with past practice;

       

      (b) reimbursement
        for expenses incurred on behalf of the Company and its Subsidiaries in the
        ordinary course of business, consistent with past practice; and

       

      (c) for
        other
        standard employee benefits made generally available to all employees (including,
        without limitation, stock option agreements outstanding under any stock option
        plan approved by the Board of Directors of the Company and each Subsidiary
        of
        the Company, as applicable).

       

      4.9 Changes.
        Since
        December 31, 2004 (the “Balance Sheet Date”), except as disclosed in the
        Exchange Act Filings or as described on Schedule
        4.9,
        there
        has not been:

       

      (i) any
        change in the consolidated assets, liabilities, financial condition or operating
        results of the Company from that reflected in the financial statements included
        in a21’s Quarterly Report on Form 10-QSB for the quarter ended September 30,
        2005, except for changes in the ordinary course of business which have not
        had
        and could not reasonably be expected to have a Material Adverse Effect,
        individually or in the aggregate;

      
        
          
          

        

        
          8

          
            

          

        

        
          
          

        

      

       

      (ii) any
        declaration or payment of any dividend, or any authorization or payment of
        any
        distribution, on any of the capital stock of the Company, or any redemption
        or
        repurchase of any securities of the Company;

       

      (iii) incurred
        any indebtedness for money borrowed or any other liabilities (other than
        ordinary course obligations) individually in excess of $100,000 or, in the
        case
        of indebtedness and/or liabilities individually less than $100,000, in excess
        of
        $250,000 in the aggregate;

       

      (iv) made
        any
        loans or advances to any person or entity not in excess, individually or
        in the
        aggregate, of $50,000.

       

      (v) any
        material damage, destruction or loss, whether or not covered by insurance
        to any
        assets or properties of the Company or its Subsidiaries;

       

      (vi) any
        waiver, not in the ordinary course of business, by the Company or any Subsidiary
        of a material right or of a material debt owed to it;

       

      (vii) any
        satisfaction or discharge of any Encumbrance or payment of any obligation
        by the
        Company or a Subsidiary, except in the ordinary course of business and which
        is
        not material to the assets, properties, financial condition, operating results
        or business of the Company and its Subsidiaries taken as a whole (as such
        business is presently conducted and as it is proposed to be
        conducted);

       

      (viii) any
        change or amendment to the Company's Certificate of Incorporation or Bylaws,
        or
        material change to any material contract or arrangement by which the Company
        or
        any Subsidiary is bound or to which any of their respective assets or properties
        is subject;

       

      (ix) any
        material labor difficulties or labor union organizing activities with respect
        to
        employees of the Company or any Subsidiary;

       

      (x) any
        material transaction entered into by the Company or a Subsidiary other than
        in
        the ordinary course of business; 

       

      (xi) the
        loss
        of the services of any key employee, or material change in the composition
        or
        duties of the senior management of the Company or any Subsidiary;
        or

       

      (xii) the
        loss
        or threatened loss of any customer which has had or could reasonably be expected
        to have a Material Adverse Effect.

      
        
          
          

        

        
          9

          
            

          

        

        
          
          

        

      

       

      4.10 Title
        to Properties and Assets; Encumbrances, Etc.
        Except
        as set forth on Schedule
        4.10,
        the
        Company and each Subsidiary has good and marketable title to all real properties
        and all other properties and assets owned by it, in each case free from all
        attachments, levies, taxes, liens, security interests and encumbrances of
        every
        kind and nature (“Encumbrances”), other than Permitted Encumbrances (as defined
        in the Master Security Agreement) that would materially affect the value
        thereof
        or materially interfere with the use made or currently planned to be made
        thereof by them; and except as disclosed in the Exchange Act Filings, the
        Company and each Subsidiary holds its leased real or personal property under
        valid and enforceable leases with, so long as the Company and such Subsidiary
        is
        in compliance with such leases, no exceptions that would materially interfere
        with the use made or currently planned to be made thereof by them. Except
        as
        disclosed in the Exchange Act Filings, the Company and each Subsidiary is
        in
        material compliance with its leased real and personal property necessary
        to
        conduct its respective businesses. 

       

      4.11 Intellectual
        Property.

       

      (a) All
        Intellectual Property (as defined below) of the Company and its Subsidiaries
        is
        currently in compliance with all legal requirements (including timely filings,
        proofs and payments of fees) and is valid and enforceable. No Intellectual
        Property of the Company or its Subsidiaries has been or is now involved in
        any
        cancellation, dispute or litigation, and, to the Company’s knowledge, no such
        action is threatened, other than those that, in each case, have not had or
        could
        not be reasonably expected to have a Material Adverse Effect. No patent owned
        by
        the Company or its Subsidiaries has been or is now involved in any interference,
        reissue, re-examination or opposition proceeding. For purposes of this
        Agreement, the term “Intellectual
        Property”
means
        all of the following to the extent necessary for the conduct of the owner’s
        business as currently conducted or as currently proposed to be conducted:
        (i)
        patents, patent applications, patent disclosures and inventions (whether
        or not
        patentable and whether or not reduced to practice); (ii) trademarks, service
        marks, trade dress, trade names, corporate names, logos, slogans and Internet
        domain names, together with all goodwill associated with each of the foregoing;
        (iii) copyrights and copyrightable works; (iv) registrations, applications
        and
        renewals for any of the foregoing; and (v) proprietary computer software
        (including but not limited to data, data bases and documentation).

       

      (b) All
        of
        the licenses and sublicenses and consent, royalty or other agreements concerning
        Intellectual Property to which the Company or any Subsidiary is a party or
        by
        which any of their assets are bound (other than  generally commercially
        available, non-custom, off-the-shelf software application programs having
        a
        retail acquisition price of less than $10,000 per license) (collectively,
        “License Agreements”) are valid and binding obligations of the Company or its
        Subsidiaries that are parties thereto and, to the Company’s knowledge, the other
        parties thereto, enforceable in accordance with their terms, except to the
        extent that enforcement thereof may be limited by bankruptcy, insolvency,
        reorganization, moratorium, fraudulent conveyance or other similar laws
        affecting the enforcement of creditors’ rights generally, and there exists no
        event or condition which will result in a material violation or breach of
        or
        constitute (with or without due notice or lapse of time or both) a default
        by
        the Company or any of its Subsidiaries under any such License Agreement other
        than, in each case, those that have not had or could not be reasonably expected
        to have a Material Adverse Effect.

      
        
          
          

        

        
          10

          
            

          

        

        
          
          

        

      

       

      (c) The
        Company and its Subsidiaries own or have the valid right to use all of the
        Intellectual Property and for the ownership, maintenance and operation of
        the
        Company’s and its Subsidiaries’ properties and assets, free and clear of all
        Encumbrances to license all such owned Intellectual Property and confidential
        information, other than licenses entered into in the ordinary course of the
        Company’s and its Subsidiaries’ businesses. Subject to the terms and conditions
        of the applicable license agreement, Company and its Subsidiaries have a
        valid
        and enforceable right to use all third party Intellectual Property and
        confidential information used or held for use in the respective businesses
        of
        the Company and its Subsidiaries.

       

      (d) The
        conduct of the Company’s and its Subsidiaries’ businesses as currently conducted
        does not infringe or otherwise impair or conflict with (collectively,
“Infringe”) any Intellectual Property rights of any third party or any
        confidentiality obligation owed to a third party, and, to the Company’s
        knowledge, the Intellectual Property and confidential information of the
        Company
        and its Subsidiaries which are necessary for the conduct of Company’s and each
        of its Subsidiaries’ respective businesses as currently conducted or as
        currently proposed to be conducted are not being Infringed by any third party
        other than those that have not had or could not reasonably be expected to
        have a
        Material Adverse Effect. There is no litigation or order pending or outstanding
        against the Company or its Subsidiaries or, to the Company’s knowledge,
        threatened or imminent, that seeks to limit or challenge or that concerns
        the
        ownership, use, validity or enforceability of any Intellectual Property or
        confidential information of the Company and its Subsidiaries and the Company’s
        and its Subsidiaries’ use of any Intellectual Property or confidential
        information owned by a third party, and, to the Company’s knowledge, there is no
        valid basis for the same.

       

      (e) The
        consummation of the transactions contemplated hereby and by the other Related
        Agreements will not result in the alteration, loss, impairment of or restriction
        on the Company’s or any of its Subsidiaries’ ownership or right to use any of
        the Intellectual Property or confidential information.

       

      (f) The
        Company and its Subsidiaries have taken commercially reasonable steps to
        protect
        the Company’s and its Subsidiaries’ rights in their Intellectual Property and
        Confidential Information.

      
        
          
          

        

        
          11

          
            

          

        

        
          
          

        

      

       

      4.12 Compliance
        with Other Instruments; No Conflict, Breach Violation or Default.
        Neither
        the Company nor any of its Subsidiaries is in violation or default of (x)
        any
        term of its respective Charter or Bylaws, or (y) any provision of any
        indebtedness, mortgage, indenture, contract, agreement or instrument to which
        it
        is party or by which it is bound or of any judgment, decree, order or writ,
        which violation or default, in the case of this clause (y), has had, or could
        reasonably be expected to have, either individually or in the aggregate,
        a
        Material Adverse Effect. The execution, delivery and performance of and
        compliance with this Agreement and the Related Agreements to which it is
        a
        party, and the issuance and sale of the Notes by the Company and the other
        Securities by the Company each pursuant hereto and thereto, will not, with
        or
        without the passage of time or giving of notice, result in any such material
        violation, or be in conflict with or constitute a default under (a) the Charter
        or Bylaws of the Company or any Subsidiary, (b) any statute, rule, regulation
        or
        order of any governmental agency or body or any court, domestic or foreign,
        having jurisdiction over the Company, any Subsidiary or any of their respective
        assets or properties or (c) any such term or provision, or result in the
        creation of any Encumbrance upon any of the properties or assets of the Company
        or any of its Subsidiaries or the suspension, revocation, impairment, forfeiture
        or nonrenewal of any permit, license, authorization or approval applicable
        to
        the Company, its business or operations or any of its assets or
        properties.

       

      4.13 Litigation.
        Except
        as set forth on Schedule
        4.13
        hereto,
        there is no action, suit, proceeding or investigation pending or, to the
        Company’s knowledge, currently threatened against the Company or any of its
        Subsidiaries that prevents the Company or any of its Subsidiaries from entering
        into this Agreement or the other Related Agreements, or from consummating
        the
        transactions contemplated hereby or thereby, or which has had, or could
        reasonably be expected to have, either individually or in the aggregate,
        a
        Material Adverse Effect.

       

      4.14 Consents.
        Except
        for the Share Increase, the execution, delivery and performance by the Company
        of the Related Agreements and the offer, issuance and sale of the Securities
        require no consent of, action by or in respect of, or filing with, any person,
        governmental body, agency, or official other than filings that have been
        made
        pursuant to applicable state securities laws and post-sale filings pursuant
        to
        applicable state and federal securities laws which the Company undertakes
        to
        file within the applicable time periods. Subject to the accuracy of the
        representations and warranties of each Purchaser set forth in Section 5 hereof,
        the Company has taken all action necessary to exempt (i) the issuance and
        sale
        of the Securities, (ii) except for the Share Increase, the issuance of the
        Conversion Shares upon the due conversion of the Notes and (iii) the other
        transactions contemplated by the Related Agreements from the provisions of
        any
        stockholder rights plan or other “poison pill” arrangement, any anti-takeover,
        business combination or control share law or statute binding on the Company
        or
        to which the Company or any of its assets and properties may be subject and
        any
        provision of the Company’s Charter or Bylaws that is or could reasonably be
        expected to become applicable to the Purchasers as a result of the transactions
        contemplated hereby, including without limitation, the issuance of the
        Securities and the ownership, disposition or voting of the Securities by
        the
        Purchasers or the exercise of any right granted to the Investors pursuant
        to
        this Agreement or the other Related Agreements. 

      
        
          
          

        

        
          12

          
            

          

        

        
          
          

        

      

       

      4.15 Tax
        Returns and Payments.
        The
        Company and each Subsidiary has timely prepared and filed all material tax
        returns required to have been filed by the Company or such Subsidiary with
        all
        appropriate governmental agencies and timely paid all material taxes shown
        thereon or otherwise owed by it. The charges, accruals and reserves on the
        books
        of the Company in respect of taxes for all fiscal periods are adequate in
        all
        material respects, and there are no material unpaid assessments against the
        Company or any Subsidiary nor, to the Company’s knowledge, any basis for the
        assessment of any additional taxes, penalties or interest for any fiscal
        period
        or, to the Company’s knowledge, audits by any federal, state or local taxing
        authority except for any assessment which is not material to the Company
        and its
        Subsidiaries, taken as a whole. All material taxes and other assessments
        and
        levies that the Company or any Subsidiary is required to withhold or to collect
        for payment have been duly withheld and collected and paid to the proper
        governmental entity or third party when due. Other than liens and taxes that
        are
        not yet due and payable, there are no tax liens or claims pending or, to
        the
        Company’s knowledge, threatened against the Company or any Subsidiary or any of
        their respective assets or property. Except as described on Schedule
        4.15,
        there
        are no outstanding tax sharing agreements or other such arrangements between
        the
        Company and any Subsidiary or other corporation or entity.

       

      4.16 Employees.

       

      (a) Except
        as
        set forth on Schedule
        4.16
        and
        disclosed in any Exchange Act Filings, neither the Company nor any Subsidiary
        is
        a party to or bound by any collective bargaining agreements or other agreements
        with labor organizations. Neither the Company nor any Subsidiary has violated
        in
        any material respect any laws, regulations, orders or contract terms, affecting
        the collective bargaining rights of employees, labor organizations or any
        laws,
        regulations or orders affecting employment discrimination, equal opportunity
        employment, or employees’ health, safety, welfare, wages and hours which has had
        or could reasonably be expected to have, either individually or in the aggregate
        a Material Adverse Effect.

       

      (b) (i)
        There
        are no labor disputes existing, or to the Company's knowledge, threatened,
        involving strikes, slow-downs, work stoppages, job actions, disputes, lockouts
        or any other disruptions of or by the Company's employees which has had or
        could
        reasonably be expected to have, either individually or in the aggregate a
        Material Adverse Effect, (ii) there are no unfair labor practices or petitions
        for election pending or, to the Company's knowledge, threatened before the
        National Labor Relations Board or any other federal, state or local labor
        commission relating to the Company's or any Subsidiary’s employees, which has
        had or could reasonably be expected to have, either individually or in the
        aggregate a Material Adverse Effect, and (iii) no demand for recognition
        or
        certification heretofore made by any labor organization or group of employees
        is
        pending with respect to the Company.

      
        
          
          

        

        
          13

          
            

          

        

        
          
          

        

      

       

      (c) The
        Company and its Subsidiaries are, and at all times have been, in compliance
        in
        all material respects with all applicable laws respecting employment (including
        laws relating to classification of employees and independent contractors)
        and
        employment practices, terms and conditions of employment, wages and hours,
        and
        immigration and naturalization. There are no claims pending against the Company
        or any Subsidiary before the Equal Employment Opportunity Commission or any
        other administrative body or in any court asserting any violation of Title
        VII
        of the Civil Rights Act of 1964, the Age Discrimination Act of 1967, 42 U.S.C.
        §§ 1981 or 1983 or any other federal, state or local Law, statute or ordinance
        barring discrimination in employment, which, in each case, has had or could
        reasonably be expected to have, either individually or in the aggregate a
        Material Adverse Effect.

       

      (d) Except
        as
        disclosed in the Exchange Act Filings or as described on Schedule
        4.16,
        neither
        the Company nor any Subsidiary is a party to, or bound by, any employment
        or
        other contract or agreement that contains any severance, termination pay
        or
        change of control liability or obligation, including, without limitation,
        any
“excess parachute payment,” as defined in Section 2806(b) of the Internal
        Revenue Code.

       

      (e) Except
        as
        specified in Schedule
        4.16,
        each of
        the Company's and its Subsidiary’s employees is a person who is either a United
        States or United Kingdom citizen or a permanent resident entitled to work
        in the
        United States or the United Kingdom. To the Company's knowledge, neither
        the
        Company nor any Subsidiary has liability for the improper classification
        by the
        Company of such employees as independent contractors or leased employees
        prior
        to the Closing.

       

      4.17 Registration
        Rights and Voting Rights.
        Except
        as set forth on Schedule
        4.17
        and
        except as disclosed in Exchange Act Filings, neither the Company nor any
        of its
        Subsidiaries is presently under any obligation, and neither the Company nor
        any
        of its Subsidiaries has granted any rights, to register any of the Company’s or
        its Subsidiaries’ presently outstanding securities or any of its securities that
        may hereafter be issued. Except as set forth on Schedule
        4.17
        and
        except as disclosed in Exchange Act Filings, to a21’s knowledge, no stockholder
        of the Company or any of its Subsidiaries has entered into any agreement
        with
        respect to the voting of equity securities of the Company or any of its
        Subsidiaries.

       

      4.18 Compliance
        with Laws; Permits.
        Neither
        the Company nor any of its Subsidiaries is in violation of any provision
        of the
        Sarbanes-Oxley Act of 2002 or any SEC related regulation or rule or any rule
        of
        the Principal Market (as hereafter defined) promulgated thereunder or any
        other
        applicable statute, rule, regulation, order or restriction of any domestic
        or
        foreign government or any instrumentality or agency thereof in respect of
        the
        conduct of its business or the ownership of its properties which has had,
        or
        could reasonably be expected to have, either individually or in the aggregate,
        a
        Material Adverse Effect. Each of the Company and its Subsidiaries has all
        franchises, permits, licenses and any similar authority necessary for the
        conduct of its business as now being conducted by it, the lack of which could,
        either individually or in the aggregate, reasonably be expected to have a
        Material Adverse Effect.

      
        
          
          

        

        
          14

          
            

          

        

        
          
          

        

      

       

      4.19 Environmental
        Matters.
        Neither
        the Company nor any Subsidiary is in violation of any statute, rule, regulation,
        decision or order of any governmental agency or body or any court, domestic
        or
        foreign, relating to the use, disposal or release of hazardous or toxic
        substances or relating to the protection or restoration of the environment
        or
        human exposure to hazardous or toxic substances (collectively, “Environmental
        Laws”), owns or operates any real property contaminated with any substance that
        is subject to any Environmental Laws, is liable for any off-site disposal
        or
        contamination pursuant to any Environmental Laws, or is subject to any claim
        relating to any Environmental Laws, which violation, contamination, liability
        or
        claim has had or could reasonably be expected to have a Material Adverse
        Effect,
        in the aggregate; and there is no pending or, to the Company’s knowledge,
        threatened investigation that might lead to such a claim.

       

      4.20 Insurance
        Coverage.
        The
        Company and each Subsidiary maintains in full force and effect insurance
        coverage that they reasonably believe is necessary for the business being
        conducted and properties owned or leased by the Company and each Subsidiary,
        and
        the Company reasonably believes such insurance coverage to be adequate against
        all material liabilities, claims and risks arising or expected to arise during
        the conduct of their respective businesses.

       

      4.21 Valid
        Offering.
        Assuming the accuracy of the representations and warranties of each Purchaser
        contained in this Agreement, the offer, sale and issuance of the Securities
        is
        exempt from the registration requirements of the Securities Act and will
        have
        been registered or qualified (or are exempt from registration and qualification)
        under the registration, permit or qualification requirements of all applicable
        state securities laws.

       

      4.22 SEC
        Reports.
        Except
        as set forth on Schedule
        4.22,
        a21 has
        filed all material proxy statements, reports and other material documents
        required to be filed by it under the Exchange Act. a21 has filed copies of:
        (i)
        its Annual Report on Form 10-KSB for its fiscal year ended December 31, 2004;
        and (ii) its Quarterly Reports on Form 10-QSB for its fiscal quarters ended
        March 31, 2005, June 30, 2005 and September 30, 2005, and (iii) the Form
        8-K
        filings which it has made during the fiscal year to date (collectively, the
“SEC
        Reports”). a21 shall file its Annual Report on Form 10-KSB for its fiscal year
        ended December 31, 2005 during the extension period for making such filing
        under
        applicable federal securities laws. Each SEC Report was, at the time of its
        filing, in compliance in all material respects with the requirements of its
        respective form and none of the SEC Reports, nor the financial statements
        (and
        the notes thereto) included in the SEC Reports, as of their respective filing
        dates, contained any untrue statement of a material fact or omitted to state
        a
        material fact required to be stated therein or necessary to make the statements
        therein, in light of the circumstances under which they were made, not
        misleading. Each registration statement and any amendment thereto filed by
        a21
        since January 1, 2003 pursuant to the Securities Act and the rules and
        regulations thereunder, as of the date such statement or amendment became
        effective, complied as to form in all material respects with the Securities
        Act
        and did not contain any untrue statement of a material fact or omit to state
        any
        material fact required to be stated therein or necessary in order to make
        the
        statements made therein not misleading; and each prospectus filed pursuant
        to
        Rule 424(b) under the Securities Act, as of its issue date and as of the
        closing
        of any sale of securities pursuant thereto did not contain any untrue statement
        of a material fact or omit to state any material fact required to be stated
        therein or necessary in order to make the statements made therein, in the
        light
        of the circumstances under which they were made, not
        misleading.

      
        
          
          

        

        
          15

          
            

          

        

        
          
          

        

      

       

      4.23 a21’s
        Listing.
        a21’s
        Common Stock is listed or quoted, as applicable, on a Principal Market (as
        hereafter defined) and satisfies and at all times hereafter will satisfy,
        all
        requirements for the continuation of such listing or quotation, as applicable.
        a21 has not received any notice that its Common Stock will be delisted from,
        or
        no longer quoted on, as applicable, the Principal Market or that its Common
        Stock does not meet all requirements for such listing or quotation, as
        applicable. For purposes hereof, the term “Principal Market” means the NASD Over
        The Counter Bulletin Board, NASDAQ Capital Market, NASDAQ National Markets
        System, American Stock Exchange or New York Stock Exchange (whichever of
        the
        foregoing is at the time the principal trading exchange or market for the
        Common
        Stock).

       

      4.24 Brokers
        and Finders.
        No
        Person will have, as a result of the transactions contemplated by the Related
        Agreements, any valid right, interest or claim against or upon the Company,
        any
        Subsidiary or a Purchaser for any commission, fee or other compensation pursuant
        to any agreement, arrangement or understanding entered into by or on behalf
        of
        the Company.

       

      4.25 No
        Directed Selling Efforts or General Solicitation.
        Neither
        the Company nor any person or entity acting on its behalf has conducted any
        general solicitation or general advertising (as those terms are used in
        Regulation D) in connection with the offer or sale of any of the
        Securities.

       

      4.26 No
        Integrated Offering.
        Neither
        the Company, nor any of its Subsidiaries or affiliates, nor any person acting
        on
        its or their behalf, has directly or indirectly made any offers or sales
        of any
        security or solicited any offers to buy any security under circumstances
        that
        would cause the offering of the Securities pursuant to this Agreement or
        any of
        the Related Agreements to be integrated with prior offerings by the Company
        for
        purposes of the Securities Act which would prevent the Company from selling
        the
        Securities pursuant to Rule 506 under the Securities Act, or any applicable
        exchange-related stockholder approval provisions, nor will the Company or
        any of
        its affiliates or Subsidiaries take any action or steps that would cause
        the
        offering of the Securities to be integrated with other offerings.

       

      4.27 Questionable
        Payments.
        Neither
        the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any of
        their respective current or former stockholders, directors, officers, employees,
        agents or other Persons acting on behalf of the Company or any Subsidiary,
        has
        on behalf of the Company or any Subsidiary or in connection with their
        respective businesses: (a) used any corporate funds for unlawful contributions,
        gifts, entertainment or other unlawful expenses relating to political activity;
        (b) made any direct or indirect unlawful payments to any governmental officials
        or employees from corporate funds; (c) established or maintained any unlawful
        or
        unrecorded fund of corporate monies or other assets; (d) intentionally made
        any
        false or fictitious entries on the books and records of the Company or any
        Subsidiary; or (e) made any unlawful bribe, rebate, payoff, influence payment,
        kickback or other unlawful payment of any nature.

      
        
          
          

        

        
          16

          
            

          

        

        
          
          

        

      

       

      4.28 Internal
        Controls.
        Other
        than as disclosed in the Exchange Act Filings, a21 is in material compliance
        with the provisions of the Sarbanes-Oxley Act of 2002 currently applicable
        to
        a21. Other than as disclosed in the Exchange Act Filings, a21 and
        the
        Subsidiaries maintain a system of internal accounting controls sufficient
        to
        provide reasonable assurance that (i) transactions are executed in accordance
        with management's general or specific authorizations, (ii) transactions are
        recorded as necessary to permit preparation of financial statements in
        conformity with GAAP and to maintain asset accountability, (iii) access to
        assets is permitted only in accordance with management's general or specific
        authorization, and (iv) the recorded accountability for assets is compared
        with
        the existing assets at reasonable intervals and appropriate action is taken
        with
        respect to any differences. a21 has established disclosure controls and
        procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for a21 and
        designed such disclosure controls and procedures to ensure that material
        information relating to a21, including the Subsidiaries, is made known to
        the
        certifying officers by others within those entities, particularly during
        the
        period in which a21’s most recently filed period report under the Exchange Act,
        as the case may be, is being prepared. a21's certifying officers have evaluated
        the effectiveness of a21's controls and procedures as of the end of the period
        covered by the most recently filed periodic report under the Exchange Act
        (such
        date, the "Evaluation Date"). a21 presented in its most recently filed periodic
        report under the Exchange Act the conclusions of the certifying officers
        about
        the effectiveness of the disclosure controls and procedures based on their
        evaluations as of the Evaluation Date. Except as set forth on Schedule 4.28,
        since the Evaluation Date, there have been no significant changes in a21's
        internal controls (as such term is defined in Item 308 of Regulation S-B)
        or, to
        a21's knowledge, in other factors that could significantly affect a21's internal
        controls. a21 maintains and will continue to maintain a standard system of
        accounting established and administered in accordance with GAAP and the
        applicable requirements of the Exchange Act.

       

      4.29 Stop
        Transfer.
        The
        Securities are restricted securities as of the date of this Agreement. Neither
        the Company nor any of its Subsidiaries will issue any stop transfer order
        or
        other order impeding the sale and delivery of any of the Securities at such
        time
        as the Securities are registered for public sale or an exemption from
        registration is available, except as required by state and federal securities
        laws.

       

      4.30 Dilution.
        Except
        for the Share Increase and the requirement to file an information statement,
        a21
        specifically acknowledges that its obligation to issue the shares of Common
        Stock upon conversion of the Notes is binding upon a21 and enforceable
        regardless of the dilution such issuance may have on the ownership interests
        of
        other shareholders of a21.

       

      4.31 Disclosures.
        The
        written materials delivered to the Purchasers in connection with the
        transactions contemplated by the Related Agreements do not contain any untrue
        statement of a material fact or omit to state a material fact necessary in
        order
        to make the statements contained therein, in light of the circumstances under
        which they were made, not misleading.

      
        
          
          

        

        
          17

          
            

          

        

        
          
          

        

      

       

      5. Representations
        and Warranties of the Purchasers.
        Each
        Purchaser, severally and not jointly, hereby represents and warrants to the
        Company as follows:

       

      5.1 No
        Shorting.
        Except
        as set forth in Section 6.20 hereof or Section 3.2(b) of the Notes, such
        Purchaser or any of its affiliates and investment partners will not and will
        not
        cause any person or entity, to directly engage in “short sales” of a21’s Common
        Stock so long as any of the Notes shall be outstanding.

       

      5.2 Requisite
        Power and Authority.
        Such
        Purchaser has all necessary power and authority under all applicable provisions
        of law to execute and deliver this Agreement and the Related Agreements and
        to
        carry out their provisions. All corporate action on such Purchaser’s part
        required for the lawful execution and delivery of this Agreement and the
        Related
        Agreements have been or will be effectively taken prior to the Closing. Upon
        their execution and delivery, this Agreement and the Related Agreements will
        be
        valid and binding obligations of such Purchaser, enforceable in accordance
        with
        their terms, except:

       

      (a) as
        limited by applicable bankruptcy, insolvency, reorganization, moratorium
        or
        other laws of general application affecting enforcement of creditors’ rights;
        and

       

      (b) as
        limited by general principles of equity that restrict the availability of
        equitable and legal remedies.

       

      5.3 Investment
        Representations.
        Such
        Purchaser understands that the Securities are being offered and sold pursuant
        to
        an exemption from registration contained in the Securities Act based in part
        upon such Purchaser’s representations contained in this Agreement, including,
        without limitation, that such Purchaser is an “accredited investor” within the
        meaning of Regulation D under the Securities Act. Such Purchaser confirms
        that
        it has received or has had full access to all the information it considers
        necessary or appropriate to make an informed investment decision with respect
        to
        the Notes to be purchased by it under this Agreement and the Conversion Shares
        acquired by it upon the conversion of the Notes purchased by it. Such Purchaser
        further confirms that it has had an opportunity to ask questions and receive
        answers from the Company regarding the Company’s and its Subsidiaries’ business,
        management and financial affairs and the terms and conditions of the Initial
        Offering or a Follow On Offering, as the case may be, the Notes purchased
        by it
        and the Securities and to obtain additional information (to the extent the
        Company possessed such information or could acquire it without unreasonable
        effort or expense) necessary to verify any information furnished to such
        Purchaser or to which such Purchaser had access.

       

      5.4 Such
        Purchaser Bears Economic Risk.
        Such
        Purchaser has substantial experience in evaluating and investing in private
        placement transactions of securities in companies similar to the Company
        so that
        it is capable of evaluating the merits and risks of its investment in the
        Company and has the capacity to protect its own interests. Such Purchaser
        must
        bear the economic risk of this investment until the Securities are sold pursuant
        to: (i) an effective registration statement under the Securities Act; or
        (ii) an
        exemption from registration is available with respect to such
        sale.

      
        
          
          

        

        
          18

          
            

          

        

        
          
          

        

      

       

      5.5 Acquisition
        for Own Account.
        Such
        Purchaser is acquiring the Notes and the Conversion Shares for such Purchaser’s
        own account for investment only, and not as a nominee or agent and not with
        a
        view towards or for resale in connection with their distribution.

       

      5.6 Such
        Purchaser Can Protect Its Interest.
        Such
        Purchaser represents that by reason of its, or of its management’s, business and
        financial experience, such Purchaser has the capacity to evaluate the merits
        and
        risks of its investment in the Note and the Securities and to protect its
        own
        interests in connection with the transactions contemplated in this Agreement
        and
        the Related Agreements. Such Purchaser did not learn of the investment in
        the
        Securities as a result of any public advertising or general
        solicitation.

       

      5.7 Accredited
        Investor.
        Each
        Purchaser represents that it is an accredited investor within the meaning
        of
        Regulation D under the Securities Act.

       

      5.8 Legends.

       

      (a) Each
        Note
        shall bear substantially the following legend:

       

      “THIS
        NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT
        BEEN
        REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE
        STATE
        SECURITIES LAWS. THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION
        OF THIS
        NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
        OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE OR SUCH SHARES UNDER
        SAID
        ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY
        SATISFACTORY TO a21, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.”

       

      (b) The
        Conversion Shares shall bear a legend which shall be in substantially the
        following form until such shares are covered by an effective registration
        statement filed with the SEC:

       

      “THE
        SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
        SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS.
        THESE SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
        THE
        ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH SECURITIES ACT
        AND
        APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
        a21
        THAT SUCH REGISTRATION IS NOT REQUIRED.”

      
        
          
          

        

        
          19

          
            

          

        

        
          
          

        

      

       

      6. Covenants
        of the Company.
        The
        Company covenants and agrees with the Purchasers as follows:

       

      6.1 Reservation
        of Common Stock; Increase of Authorized Capital.

       

      (a) After
        completing the Share Increase, a21 shall at all times reserve and keep available
        out of its authorized but unissued shares of Common Stock, solely for the
        purpose of providing for the conversion of the Notes, such number of shares
        of
        Common Stock as shall from time to time equal the Conversion Shares issuable
        upon the due conversion of the Notes in accordance with the terms of the
        Notes.

       

      (b) a21
        will
        take all action necessary in accordance with the laws of the State of Texas
        and
        a21’s Charter and Bylaws to obtain the necessary consent from its shareholders
        to increase its authorized shares of Common Stock to allow for the full
        conversion of the Notes into Common Stock and to reincorporate a21 in the
        State
        of Delaware and a21 will use its commercially reasonable efforts to obtain
        such
        consent as soon as practicable after the date of this Agreement, but in no
        event
        later than July 30, 2006. a21’s Board of Directors will recommend that the
        shareholders’ consent to the increase of the authorized shares of Common Stock
        and the reincorporation in the State of Delaware by a21’s shareholders as
        provided herein and will use its commercially reasonable efforts to solicit
        such
        consent and provide any necessary notification pursuant to state and federal
        law, including securities laws, and a21’s Charter and Bylaws to those
        shareholders who have not consented.

       

      6.2 Stop-Orders.
        a21
        will advise the Agent, promptly after it receives notice of issuance by the
        SEC,
        any state securities commission or any other regulatory authority of any
        stop
        order or of any order preventing or suspending any offering of any securities
        of
        a21, or of the suspension of the qualification of the Common Stock of a21
        for
        offering or sale in any jurisdiction, or the initiation of any proceeding
        for
        any such purpose.

       

      6.3 Listing.
        a21
        shall use commercially reasonable efforts to secure the listing or quotation,
        as
        applicable, of the shares of Common Stock issuable upon conversion of the
        Note
        on the Principal Market upon which shares of Common Stock are listed or quoted
        for trading, as applicable (subject to official notice of issuance) and shall
        maintain such listing or quotation, as applicable, so long as any other shares
        of Common Stock shall be so listed or quoted, as applicable. Once secured,
        a21
        will maintain the listing or quotation, as applicable, of its Common Stock
        on
        the Principal Market, and will comply in all material respects with the
        Company’s reporting, filing and other obligations under the bylaws or rules of
        the National Association of Securities Dealers (“NASD”) and such exchanges, as
        applicable.

       

      6.4 Market
        Regulations.
        a21
        shall notify the SEC, NASD and applicable state authorities, in accordance
        with
        their requirements, of the transactions contemplated by this Agreement, and
        shall take all other necessary action and proceedings as may be required
        and
        permitted by applicable law, rule and regulation, for the legal and valid
        issuance of the Securities to the Purchasers and promptly provide copies
        thereof
        to Agent.

      
        
          
          

        

        
          20

          
            

          

        

        
          
          

        

      

       

      6.5 Reporting
        Requirements.
        To the
        extent the same is not available electronically at www.sec.gov, subject to
        the
        last paragraph of Section 6.7 hereof, the Company will deliver, or cause
        to be
        delivered, to the Agent each of the following, which shall be in form and
        detail
        acceptable to the Agent:

       

      (a) As
        soon
        as available, and in any event within one hundred and five (105) days after
        the
        end of each fiscal year of the Company, each of the Company’s and each of its
        Subsidiaries’ audited financial statements with a report of BDO or other
        independent certified public accountants of recognized standing selected
        by the
        Company and acceptable to Agent (as defined in the Master Security Agreement)
        (the “Accountants”), which annual financial statements shall be without
        qualification (other than a going concern qualification) and shall include
        each
        of the Company’s and each of its Subsidiaries’ balance sheet as at the end of
        such fiscal year and the related statements of each of the Company’s and each of
        its Subsidiaries’ income, retained earnings and cash flows for the fiscal year
        then ended, prepared on a consolidated basis to include the Company, each
        Subsidiary of the Company and each of their respective affiliates, all in
        reasonable detail and prepared in accordance with GAAP, together with (i)
        if and
        when available, copies of any management letters prepared by the Accountants;
        and (ii) a certificate of the Company’s President, Chief Executive Officer or
        Chief Financial Officer stating that such financial statements have been
        prepared in accordance with GAAP and whether or not such officer has knowledge
        of the occurrence of any Event of Default (as defined in the Notes) and,
        if so,
        stating in reasonable detail the facts with respect thereto;

       

      (b) As
        soon
        as available and in any event within forty five (45) days after the end of
        each
        fiscal quarter of the Company, an unaudited/internal balance sheet and
        statements of income, retained earnings and cash flows of the Company and
        each
        of its Subsidiaries as at the end of and for such quarter and for the year
        to
        date period then ended, prepared on a consolidated basis to include the Company,
        each Subsidiary of the Company and each of their respective affiliates, in
        reasonable detail and stating in comparative form the figures for the
        corresponding date and periods in the previous year, all prepared in accordance
        with GAAP (other than the absence of footnotes), subject to year-end adjustments
        and accompanied by a certificate of the Company’s President, Chief Executive
        Officer or Chief Financial Officer, stating (i) that such financial statements
        have been prepared in accordance with GAAP (other than the absence of
        footnotes), subject to year-end audit adjustments, and (ii) whether or not
        such
        officer has knowledge of the occurrence of any Event of Default (as defined
        in
        the Notes) not theretofore reported and remedied and, if so, stating in
        reasonable detail the facts with respect thereto; and

      
        
          
          

        

        
          21

          
            

          

        

        
          
          

        

      

       

      (c) a21
        shall
        timely file with the SEC all reports required to be filed pursuant to the
        Exchange Act and refrain from terminating its status as an issuer required
        by
        the Exchange Act to file reports thereunder even if the Exchange Act or the
        rules or regulations thereunder would permit such termination. Promptly after
        (i) the filing thereof, copies of a21’s most recent registration statements and
        annual, quarterly, or other regular reports which a21 files with the SEC,
        and
        (ii) the issuance thereof, copies of such financial statements, reports and
        proxy statements as a21 shall send to its stockholders.

       

      6.6 Use
        of
        Funds.
        The
        Company shall use the proceeds of the sale of the Notes for (a) general working
        capital purposes, (b) repaying up to $4,500,000 of existing indebtedness
        and (c)
        making acquisitions of the assets and/or equity of any person or
        entity.

       

      6.7 Access
        to Facilities.
        Each of
        the Company and each of its Subsidiaries will permit any representatives
        designated by Agent and StarVest (as defined herein) (or any successor of
        Agent), upon reasonable notice and during normal business hours, at such
        person’s expense and accompanied by a representative of the Company or any
        Subsidiary to:

       

      (a) visit
        and
        inspect any of the properties of the Company or any of its
        Subsidiaries;

       

      (b) examine
        the corporate and financial records of the Company or any of its Subsidiaries
        (unless such examination is not permitted by federal, state or local law
        or by
        contract); and

       

      (c) discuss
        the affairs, finances and accounts of the Company or any of its Subsidiaries
        with the directors and executive officers of the Company or any of its
        Subsidiaries.

       

      Notwithstanding
        the foregoing and Section 6.5 hereof, the Company shall not disclose material
        nonpublic information to the Agent or any Purchaser, or to advisors to or
        representatives of the Agent or such Purchaser, unless prior to disclosure
        of
        such information, the Company identifies such information as being material
        nonpublic information and provides the Agent or such Purchaser or advisors
        and
        representatives with the opportunity to accept or refuse to accept such material
        nonpublic information for review and the Agent or any Purchaser wishing to
        obtain such information enters into an appropriate confidentiality agreement
        with the Company that complies with Regulation FD under the federal securities
        laws.

       

      6.8 Conduct
        of Business.
        The
        Company shall and shall cause each of its Subsidiaries to (A) carry on and
        conduct its business in substantially the same manner and in substantially
        the
        same fields of enterprise as it is presently conducting, (B) do all things
        necessary to remain duly organized, validly existing, and in good standing
        as a
        domestic corporation under the laws of its state of incorporation and (C)
        maintain all requisite authority to conduct its business in those jurisdictions
        in which its business is conducted.

      
        
          
          

        

        
          22

          
            

          

        

        
          
          

        

      

       

      6.9 Change
        of Business; Misstatements.
        The
        Company shall promptly notify the Agent in writing of (A) any change in the
        business or the operations of the Company or any Subsidiary which could
        reasonably be expected to have a Material Adverse Effect, and (B) any
        information which indicates that any financial statements which are the subject
        of any representation contained in the Related Agreements, or which are
        furnished to the Agent or any Purchaser pursuant to the Related Agreements,
        fail, in any material respect, to present fairly, as of the date thereof
        and for
        the period covered thereby, the financial condition and results of operations
        purported to be presented therein, disclosing the nature thereof.

       

      6.10 Notice
        of Event of Default.
        The
        Company shall promptly notify the Agent of the occurrence of any Event of
        Default (as defined in the Notes) or any event which, with the giving of
        notice,
        the lapse of time or both would constitute an Event of Default under the
        Notes,
        which notice shall include a written statement as to such occurrence, specifying
        the nature thereof and the action (if any) which is proposed to be taken
        with
        respect thereto.

       

      6.11 Suits
        and Proceedings.
        The
        Company shall promptly notify the Agent of any action, suit or proceeding
        at law
        or in equity or by or before any governmental instrumentality or other agency
        against the Company or any Subsidiary or to which the Company or any Subsidiary
        may be subject which alleges damages in excess of two percent (2%) of the
        Company and its Subsidiaries (on a consolidated basis) trailing twelve (12)
        month gross revenue.

       

      6.12 Material
        Breach of Contract.
        The
        Company shall promptly notify the Agent of any default in the performance,
        observance or fulfillment of any of the obligations, covenants or conditions
        contained in any agreement or instrument to which the Company or any Subsidiary
        is a party, including this Agreement and the Related Agreements, which default
        could reasonably be expected to have a Material Adverse Effect.

       

      6.13 Officer’s
        Certificate.
        The
        Company shall deliver to the Agent, simultaneously with the filing of its
        10QSB
        and 10KSB,
        a
        certificate signed by either the Chief Executive Officer or the Chief Financial
        Officer of the Company (which shall include an updated perfection certification)
        as to such officer’s knowledge, of the Company’s compliance with all conditions
        and covenants under the Related Agreements (without regard to any period
        of
        grace or requirement of notice provided hereunder) and in the event any Event
        of
        Default under the Notes or any event which, with the giving of notice, the
        lapse
        of time or both would constitute an Event of Default under the Notes exists,
        such officer shall specify the nature thereof.

      
        
          
          

        

        
          23

          
            

          

        

        
          
          

        

      

       

      6.14 Taxes.
        Each of
        the Company and each of its Subsidiaries will promptly pay and discharge,
        or
        cause to be paid and discharged, when due and payable, all material taxes,
        assessments and governmental charges or levies imposed upon the income, profits,
        property or business of the Company and its Subsidiaries; provided, however,
        that any such tax, assessment, charge or levy need not be paid currently
        if (i)
        the validity thereof shall currently and diligently be contested in good
        faith
        by appropriate proceedings, (ii) such tax, assessment, charge or levy shall
        have
        no effect on the lien priority of the Agent in any property of the Company
        or
        any of its Subsidiaries or (iii) if the Company and/or such Subsidiary shall
        have set aside on its books adequate reserves with respect thereto in accordance
        with GAAP; and provided, further, that the Company and its Subsidiaries will
        pay
        all such taxes, assessments, charges or levies forthwith upon the commencement
        of proceedings to foreclose any lien which may have attached as security
        therefor.

       

      6.15 Intellectual
        Property.
        At its
        own expense, the Company shall and shall cause each Subsidiary to make, execute,
        endorse, acknowledge file and/or deliver any documents and take all actions
        necessary or required to maintain its ownership rights in its Intellectual
        Property including, without limitation, (i) any action reasonably required
        to
        protect the Intellectual Property in connection with any infringement, suspected
        infringement, passing off, act of unfair competition or other unlawful
        interference with the rights of the Company or any Subsidiary in and to such
        Intellectual Property, and (ii) any registrations with the United States
        Patent
& Trademark Office and any corresponding foreign patent and/or trademark
        office required for the Company or any Subsidiary to carry on its business
        as
        presently conducted and as presently proposed to be conducted. Except for
        licenses granted in the ordinary course of business, the Company shall not
        and
        shall cause each Subsidiary not to transfer, assign or otherwise convey the
        Intellectual Property, any registrations or applications thereof and all
        goodwill associate therewith, to any person or entity.

       

      6.16 Properties.
        Each of
        the Company and each of its Subsidiaries will keep its properties in good
        repair, working order and condition, reasonable wear and tear excepted, and
        from
        time to time make all needful and proper repairs, renewals, replacements,
        additions and improvements thereto; and each of the Company and each of its
        Subsidiaries will at all times comply with each provision of all leases to
        which
        it is a party or under which it occupies property if the breach of such
        provision could, either individually or in the aggregate, reasonably be expected
        to have a Material Adverse Effect.

       

      6.17 No
        Conflicting Agreements.
        Neither
        the Company nor any Subsidiary will take any action, enter into any agreement
        or
        make any commitment that would conflict or interfere in any material respect
        with the Company’s obligations to the Purchasers under this Agreement and the
        Related Agreements.

       

      6.18 Insurance.
        The
        Company shall and shall cause each Subsidiary to all times maintain with
        financially sound and reputable insurance companies insurance covering its
        assets and its businesses in such amounts and covering such risks (including,
        without limitation, hazard, business interruption and public liability) as
        is
        consistent with sound business practice and as may be obtained at commercially
        reasonable rates.

      
        
          
          

        

        
          24

          
            

          

        

        
          
          

        

      

       

      6.19 Compliance
        with Laws.
        The
        Company shall and shall cause each Subsidiary to comply with all laws, rules,
        regulations, orders, writs, judgments, injunctions, decrees or awards to
        which
        they may be subject except where the failure to so comply could not reasonably
        be expected to have a Material Adverse Effect.

       

      6.20 Removal
        of Legends.
        To the
        extent permitted under applicable law, upon the earlier of (i) registration
        for
        resale pursuant to the Registration Rights Agreement or (ii) Rule 144(k)
        becoming available, a21 shall (A) deliver to the transfer agent for the Common
        Stock (the “Transfer Agent”) irrevocable instructions that the Transfer Agent
        shall issue certificates representing the Conversion Shares without legends
        upon
        receipt by such Transfer Agent of the Notes or any legended certificates
        previously issued for such shares, together with either (1) a customary
        representation by the Purchaser that Rule 144(k) applies to the shares of
        Common
        Stock to be represented thereby or (2) a statement by the Purchaser that
        such
        Purchaser has sold the shares of Common Stock represented thereby in accordance
        with the Plan of Distribution contained in the Registration Statement, and
        (B)
        cause its counsel to deliver to the Transfer Agent one or more blanket opinions
        to the effect that the issuance of such unlegended certificates in such
        circumstances may be effected under the Securities Act. From and after the
        earlier of such dates, upon a Purchaser’s written request, the Company shall
        promptly cause replacement Securities to be issued without restrictive legends
        and/or legended certificates representing previously issued Conversion Shares
        to
        be replaced with certificates which do not bear such restrictive legends,
        and
        Conversion Shares subsequently issued upon due conversion of the Notes shall
        not
        bear such restrictive legends provided the provisions of either clause (i)
        or
        clause (ii) above, as applicable, are satisfied with respect to such Conversion
        Shares. When the Company is required to cause unlegended Securities to replace
        previously issued legended Securities, if unlegended Securities are not
        delivered to or able to be obtained by a Purchaser within three (3) business
        days of submission by that Purchaser of legended Securities to the Transfer
        Agent as provided above (or to the Company, in the case of the Notes), so
        long
        as such failure is not a direct result of such Purchaser’s actions or failure to
        act, to the extent permitted under applicable law, such Purchaser shall be
        entitled to engage in “short sales” with respect to the number of Conversion
        Shares requested to be issued pursuant to this Section 6.20.

       

      6.21 Director
        Designee.

       

      (a) So
        long
        as StarVest Partners, L.P. and its affiliates (“StarVest”), continue to
        beneficially own at least 8,000,000 shares (on an as converted basis and
        as such
        number may be adjusted by stock splits, stock dividends, stock distributions,
        reverse splits, reclassifications, reorganizations or combinations but, for
        avoidance of doubt, such number will not be adjusted for the mere issuance
        of
        more authorized shares) of the outstanding shares of Common Stock, StarVest
        shall have the right to designate one person for election to the Board of
        Directors of a21 (the “StarVest Designee”). a21 shall nominate the StarVest
        Designee and use its commercially reasonable efforts to cause the StarVest
        Designee to be elected to the Company’s Board of Directors no later than the
        next annual meeting of the shareholders of a21. StarVest shall have the right
        to
        remove or replace any StarVest Designee by giving written notice to such
        StarVest Designee and a21. a21 shall use its commercially reasonable efforts
        to
        effect the removal or replacement of any such StarVest Designee. Until the
        StarVest Designee is elected to the Board of Directors of a21, the StarVest
        Designee shall have non-participatory observation rights on such Board of
        Directors and shall receive all information received by members of the Board
        of
        Directors. 

      
        
          
          

        

        
          25

          
            

          

        

        
          
          

        

      

       

      (b) Subject
        to any limitations imposed by the SEC, applicable state or federal securities
        laws, or the Principal Market on which a21’s Common Stock is then listed or
        quoted and so long as the following does not directly prevent a21’s Common Stock
        from being listed or quoted on any Principal Market (all of the foregoing
        limitations and restrictions, the “Legal Restrictions”), (i) the StarVest
        Designee shall be entitled to serve as a member of a21’s compensation committee
        and, in the event the StarVest Designee is not entitled to serve as a member
        of
        a21’s compensation committee as a result of any of the Legal Restrictions, then
        the StarVest Designee shall, subject to any Legal Restriction, have
        non-participatory observation rights on the compensation committee of the
        Board
        of Directors and (b) subject to any limitations imposed by applicable law,
        the
        StarVest Designee shall be entitled to the same perquisites, including stock
        options, reimbursement of expenses and other similar rights in connection
        with
        such person's membership on the Board of Directors of a21, as every other
        non-employee member of the Board of Directors of a21. In addition, subject
        to
        any Legal Restriction, the StarVest Designee shall have non-participatory
        observation rights on the audit committee.

       

      6.22 Required
        Approvals.
        For so
        long as at least forty percent (40%) of the principal amount of the Notes
        are
        outstanding, the Company, without the prior written consent of Agent, shall
        not
        permit any of its Subsidiaries to:

       

      (a) directly
        or indirectly, declare or pay any dividends on account of any shares of any
        class or series of its capital stock now or hereafter outstanding, or set
        aside
        or otherwise deposit or invest any sums for such purpose, or redeem, retire,
        defease, purchase or otherwise acquire any shares of any class of its capital
        stock (or set aside or otherwise deposit or invest any sums for such purpose)
        for any consideration or apply or set apart any sum, or make any other
        distribution (by reduction of capital or otherwise) in respect of any such
        shares or optionally prepay, redeem, retire, defease or repurchase any
        indebtedness for borrowed money (as the same would be required to be reflected
        on a balance sheet prepared in accordance with GAAP (or set aside or otherwise
        deposit or invest any sums for such purpose)) or apply or set apart any sum,
        or
        make any other payment in respect thereof or agree to do any of the foregoing
        (each of the foregoing is herein called a “Restricted
        Payment”);
        provided, that (i) any Subsidiary directly or indirectly wholly owned by
        the
        Company may pay dividends on its capital stock and (ii) the Company may
        repurchase capital stock from a former employee in connection with the
        termination or other departure of such employee, strictly in accordance with
        the
        terms of any agreement entered into with such employee and in effect on the
        Closing Date, provided that (A) such repurchase is approved by a majority
        of the
        independent directors on the Board of Directors of a21, (B) payments permitted
        under this clause (ii) shall not exceed $500,000 in the aggregate, and (C)
        no
        such payment may be made if an Event of Default or an event which, with the
        giving of notice, the lapse of time or both would constitute an Event of
        Default
        has occurred and is continuing or would result from such payment, and (iii)
        the
        Company and any Subsidiary may make any non-cash exercise of a warrant, option
        or other equity interest;

      
        
          
          

        

        
          26

          
            

          

        

        
          
          

        

      

       

      (b) liquidate,
        dissolve or effect a material reorganization or Change of Control provided,
        that
        (i) a21 may reincorporate in the State of Delaware at any time and (ii) the
        Company or any Subsidiaries may enter into any other transaction pursuant
        to
        which the Purchasers, upon the consummation of such transaction, may convert
        the
        remaining outstanding balance of the Notes for consideration being offered
        to
        other shareholders of Common Stock pursuant to the terms of such transaction
        at
        a valuation equal to the greater of (a) $1.00 per share of Common Stock,
        (b) the
        then market value per share of the Common Stock and (c) the consideration
        being
        paid per share of Common Stock pursuant to the terms of such transaction.
        The
        term “Change of Control” shall mean (a) in any one or series of related or
        unrelated transactions (i) the sale of all or substantially all of the assets
        of
        the Company, (ii) the merger or consolidation of the Company with another
        corporation or entity in which the Company is not the surviving entity, (iii)
        the acquisition by any single person or entity or related persons or entities
        of
        more than fifty percent (50%) of the outstanding and issued voting securities
        of
        the Company or (iv) a merger or consolidation of the Company with another
        corporation or entity that results in the former shareholders of the Company,
        as
        they existed immediately prior to such merger or consolidation, owning in
        the
        aggregate less than 50% of the outstanding voting securities of the surviving
        or
        resulting corporation or entity, or (b) during any period of two consecutive
        years, when individuals who at the beginning of such period constitute the
        Board
        of Directors of the Company cease for any reason to constitute at least a
        majority thereof, unless the election, or the nomination for election by
        the
        shareholders of the Company, of each new director was approved by a vote
        of at
        least a majority of the directors then still in office who were directors
        at the
        beginning of such period; 

       

      (c) become
        subject to (including, without limitation, by way of amendment to or
        modification of) any agreement or instrument which by its terms would (under
        any
        circumstances) restrict the Company’s or any of its Subsidiaries, right to
        perform the provisions of this Agreement, any Related Agreement or any of
        the
        agreements contemplated hereby or thereby;

      
        
          
          

        

        
          27

          
            

          

        

        
          
          

        

      

       

      (d) (i)
        create, incur, guaranty, assume or suffer to exist any indebtedness (exclusive
        of trade debt and debt incurred to finance the purchase of equipment in the
        ordinary course of business consistent with past practice) whether secured
        or
        unsecured other than (A) the Company’s obligations owed to the Purchasers, (B)
        indebtedness disclosed on Exchange Act Filings or set forth on Schedule
        6.10(d)
        attached
        hereto and made a part hereof and any refinancings or replacements thereof
        on
        then market terms, (C) any indebtedness incurred in connection with the purchase
        of assets (other than equipment) in the ordinary course of business, or any
        refinancings or replacements thereof on then market terms, so long as any
        Encumbrance relating thereto shall only encumber the fixed assets so purchased
        and no other assets of the Company or any of its Subsidiaries, (D) indebtedness
        incurred in connection with the acquisition of the assets or equity interests
        of
        a person or entity so long as such indebtedness does not exceed 40% of the
        purchase price of such acquisition provided, that, such indebtedness shall
        be
        subordinated (on typical terms and conditions) to $3,000,000 of the Notes
        (on a
        pro rata basis) and shall be senior in debt priority to the remaining
        outstanding balance of the Notes, (E) up to $5,000,000 in aggregate of senior
        secured indebtedness which shall be senior in debt priority to Notes (on
        typical
        terms and conditions), (F) up to $1,000,000 in the aggregate of secured
        indebtedness incurred solely for working capital purposes by a21’s direct or
        indirect foreign Subsidiaries, (G) intercompany indebtedness of the Company
        and
        its Subsidiaries which is incurred from and owing to each other and (H) up
        to
        $250,000 in the aggregate of unsecured indebtedness; (ii) cancel any
        indebtedness owing to it in excess of $250,000 in the aggregate during any
        12
        month period; (iii) assume, guarantee, endorse or otherwise become directly
        or
        contingently liable in connection with any obligations of any other person
        or
        entity, except the endorsement of negotiable instruments by the Company or
        any
        Subsidiary thereof for deposit or collection or similar transactions in the
        ordinary course of business or guarantees of indebtedness otherwise permitted
        to
        be outstanding pursuant to this clause (e) except a21 may not guarantee the
        indebtedness of any of its subsidiaries permitted to be outstanding pursuant
        to
        clause (i)(C) above (clauses (A) through (H), “Permitted
        Indebtedness”);

       

      (e) create
        or
        acquire any Subsidiary after the date hereof unless (i) such Subsidiary is
        a
        wholly-owned Subsidiary of the Company or one of its Subsidiaries and (ii)
        such
        Subsidiary, if formed in the United States, becomes a party to the Master
        Security Agreement and the Notes (either by executing a counterpart thereof
        or
        an assumption or joinder agreement in respect thereof);

       

      (f) create,
        incur, assume or suffer to exist any Encumbrance upon any of its property,
        whether now owned or hereafter acquired other than (i) Encumbrances created
        pursuant to the Master Security Agreement and (ii) Permitted Encumbrances.
        The
        Company shall not, and shall cause each Subsidiary not to, be bound by any
        agreement which limits the ability of the Company or any Subsidiary to grant
        Encumbrances (other than with respect to Excluded Property (as such term
        is
        defined in the Master Security Agreement);

      
        
          
          

        

        
          28

          
            

          

        

        
          
          

        

      

       

      (g) directly
        or indirectly, enter into or permit to exist any transaction or series of
        related transactions (including, without limitation, the purchase, sale,
        lease
        or exchange of any property or the rendering of any service) with, or for
        the
        benefit of, any of employee, officer, director or 10% stockholder, other
        than a
        wholly owned Subsidiary or other than as holders of stock options and/or
        warrants, and for services as employees, officers and directors;

       

      (h) sell,
        lease, assign, transfer or otherwise dispose of any of its now owned or
        hereafter acquired assets (including, without limitation, shares of stock
        and
        indebtedness, receivables and leasehold interests), except in the ordinary
        course of business consistent with past practices;

       

      (i) directly
        or indirectly, engage in any business other than the business of the production,
        management and distribution of media, digital or otherwise, to businesses
        and
        consumers; 

       

      (j) settle,
        or agree to indemnify or defend third parties against, any material lawsuit,
        except as may be required by judicial or regulatory order or by agreements
        entered into prior to the date hereof on a basis consistent with past practice.
        A material lawsuit shall be any lawsuit in which the amount in controversy
        exceeds two percent (2%) of the gross revenue of the Company and its
        Subsidiaries, on a consolidated basis, for the trailing twelve (12) months;
        and

       

      (k) amend
        its
        bylaws, certificate of incorporation or other charter document in a manner
        adverse to the Holder.

       

      The
        Company, its Subsidiaries, and the Agent, on behalf of the Purchasers, hereby
        agree to, enter into subordination and intercreditor agreements in connection
        with the incurrence of the indebtedness described in clauses (d)(i)(D) and
        (d)(i)(E) above to reflect the relative debt and lien priorities of the
        applicable parties as set forth in clause (d)(i)(D) and (d)(i)(E)
        above.

       

      6.23 Margin
        Stock.
        The
        Company will not permit any of the proceeds of the Note to be used directly
        or
        indirectly to “purchase” or “carry” “margin stock” or to repay indebtedness
        incurred to “purchase” or “carry” “margin stock” within the respective meanings
        of each of the quoted terms under Regulation U of the Board of Governors
        of the
        Federal Reserve System as now and from time to time hereafter in
        effect.

      
        
          
          

        

        
          29

          
            

          

        

        
          
          

        

      

       

      6.24 Option
        to Participate in Future Financings.
        Purchasers, on a pro rata basis, shall have a right to provide up to 25%
        of the
        amount of any Additional Financing (as defined below) to be issued by a21,
        subject to the following terms and conditions. From and after the date hereof,
        prior to the incurrence by a21, in any one transaction, of additional
        indebtedness for borrowed money or the issuance of equity in an amount in
        excess
        of $2,000,000 (an “Additional Financing”), a21 shall notify Purchasers, who are
        then holders of a Note, of its intention to enter into such Additional
        Financing. In connection therewith, a21 shall submit a term sheet (a “Proposed
        Term Sheet”) to the Purchasers setting forth the material terms, conditions and
        pricing of any such Additional Financing (such financing to be negotiated
        on
“arm’s length” terms and the terms thereof to be negotiated in good faith)
        proposed to be entered into by a21. So long as a Purchaser is a holder of
        a Note
        at such time, such Purchaser shall, on a pro rata basis, have the right,
        but not
        the obligation, to provide up to 25% of any such Additional Financing (an
        “Option”). Any Purchaser that would like to exercise an Option, shall deliver a
        written notice to a21 within five (5) business days after receiving the
        applicable Proposed Term Sheet (such notice, an “Option Notice”). If a Purchaser
        shall not have delivered an Option Notice within five (5) business days of
        receiving a Proposed Term Sheet, such Purchaser shall be deemed to have rejected
        the right to participate in the related Additional Financing and the applicable
        Option shall immediately terminate provided, that any Purchaser (the “Assignee
        Purchaser”) may provide any other Purchaser’s (a “Assignor Purchaser”) pro rata
        share of an Additional Financing, so long as such Assignee Purchaser shall
        have
        delivered an Option Notice within five (5) business days of receiving the
        applicable Proposed Term Sheet, such Option Notice indicates that such Assignee
        Purchaser is willing to provide such Assignor Purchaser’s pro rata share of such
        Additional Financing and the Assignor Purchaser has indicated on such Option
        Notice, to a21’s reasonable satisfaction, that it consents to such Assignee
        Purchaser providing such Assignor Purchasers pro rata share of such Additional
        Financing. In addition, to the extent a Purchaser has delivered an Option
        Notice
        in accordance with this Section 6.24, the Additional Financing related to
        such
        Option Notice shall not close, without the written consent of such Purchaser,
        prior to the fifteenth (15th)
        business day after such Purchaser received the applicable Proposed Term
        Sheet.

       

      6.25 Form
        D; Blue Sky Filings.
        The
        Company agrees to timely file a Form D with respect to the Initial Notes
        and
        Future Notes as required under Regulation D and to provide a copy thereof
        to the
        Agent promptly after such filing. The Company shall, on or before each of
        the
        closing dates for such transactions, take such action as the Company shall
        reasonably determine is necessary in order to obtain an exemption for, or
        to
        qualify the Initial Notes and Future Notes for, sale to the Purchaser, as
        applicable, at each of the closings and issuance to the Purchaser, as
        applicable, on each closing date for such transactions pursuant to this
        Agreement under applicable securities or “Blue Sky” laws of the states of the
        United States, and shall provide evidence of any such action so taken to
        the
        Agent, on or prior to each of the closing dates for such transactions. The
        Company shall make all filings and reports relating to the offer and sale
        by the
        Company of the Initial Notes and Future Notes required under applicable
        securities or “Blue Sky” laws of the states of the United States following each
        of the closing dates for such transactions.

      
        
          
          

        

        
          30

          
            

          

        

        
          
          

        

      

       

      7. Covenants
        of the Purchasers.
        Each
        Purchaser covenants and agrees with a21 as follows:

       

      7.1 Confidentiality.
        Such
        Purchaser will not disclose, and will not include in any public announcement,
        the name of the Company, unless expressly agreed to by the Company or unless
        and
        until such disclosure is required by law or applicable regulation, and then
        only
        to the extent of such requirement.

       

      7.2 Non-Public
        Information.
        Such
        Purchaser will not effect any sales in the shares of a21’s Common Stock while in
        possession of material, non-public information regarding a21.

       

      7.3 Share
        Increase.
        If such
        Purchaser is an owner of Common Stock (as of the record date for voting on
        the
        Share Increase), such Purchaser shall vote all of its shares of Common Stock
        for
        the Share Increase. Upon the request of a21, such Purchasers shall deliver
        to
        a21 the necessary written authorization to vote all of their Common Stock
        for
        the Share Increase.

       

      7.4 Tax
        Information.
        Each
        Purchaser that is organized under the laws of any jurisdiction other than
        the
        United States or any state or political subdivision thereof agrees (i)
        to furnish to Company (x) either IRS Form W-8BEN or IRS Form W-8ECI, in
        each case certifying such Purchaser’s entitlement to a complete exemption from,
        or a reduced rate of, United States federal withholding tax on all payments
        made
        hereunder or under any Related Agreement, (y) to the extent that such Purchaser
        does not act or ceases to act for its own account with respect to any portion
        of
        any amounts paid or payable to such Purchaser hereunder or under any Related
        Agreement, IRS Form W-8IMY together with any information such Purchaser chooses
        to transmit with such form, and any other certificate or statement required
        under applicable United States laws and regulations, to establish that such
        Purchaser is not acting for its own account with respect to a portion of
        any
        such amounts paid or payable to such Purchaser or (z) any other form,
        certificate or document prescribed by the Internal Revenue Service (the “IRS”)
        certifying as to such Purchaser’s entitlement to complete exemption from, or a
        reduced rate of, United States federal withholding tax on all payments made
        hereunder or under any Related Agreement, (ii) to provide to Company new
        forms upon the obsolescence of any previously delivered forms and comparable
        statements in accordance with applicable United States laws and regulations
        and
        amendments, duly executed and completed by such Purchaser, and (iii) to comply
        from time to time with all applicable United States laws and regulations
        with
        regard to such withholding tax exemption or reduction in withholding tax
        rate.
        Notwithstanding any other provision of this Section 7.4, no Purchaser that
        is
        organized under the laws of any jurisdiction other than the United States
        or any
        state or political subdivision thereof shall be required to deliver after
        the
        date such Purchaser became a party to this Agreement any form, certificate,
        document or statement pursuant to this Section 7.4 that such Purchaser is
        not
        legally entitled to deliver. Each Company shall be entitled, to the extent
        it is
        required to do so by law, to deduct or withhold tax liabilities imposed by
        the
        United States (or any political subdivision or taxing authority thereof or
        therein) from interest, fees or other amounts payable hereunder for the account
        of any Purchaser that is organized under the laws of any jurisdiction other
        than
        the United States or any state or political subdivision thereof to the extent
        that such Purchaser has not provided to such Company IRS forms that establish
        entitlement to a complete exemption from, or a reduced rate of, United States
        federal withholding tax (and each Company hereby agrees to give Agent prompt
        written notice in the event that it is required to so deduct or
        withhold).

      
        
          
          

        

        
          31

          
            

          

        

        
          
          

        

      

       

      8. Indemnification.

       

      8.1 Company
        Indemnification.
        Each
        Company, jointly and severally, agrees to indemnify, hold harmless, reimburse
        and defend the Purchasers and the Agent, each of the Purchasers’ and Agent’s
        respective officers, directors, agents, affiliates, control persons, and
        principal shareholders, against all claims, costs, expenses, liabilities,
        obligations, losses or damages (including reasonable legal fees and expenses)
        of
        any nature, incurred by or imposed upon any of the foregoing persons or entities
        which result, arise out of or are based upon: (i) any misrepresentation by
        the
        Company or any of its Subsidiaries or breach of any warranty by the Company
        or
        any of its Subsidiaries in this Agreement, any other Related Agreement or
        in any
        exhibits or schedules attached hereto or thereto; or (ii) any breach or default
        in performance by Company or any of its Subsidiaries of any covenant or
        undertaking to be performed by Company or any of its Subsidiaries hereunder,
        under any other Related Agreement or any other agreement entered into by
        the
        Company and/or any of its Subsidiaries and any Purchaser relating hereto
        or
        thereto. 

       

      8.2 Conduct
        of Indemnification Proceedings.
        Promptly after receipt by any person or entity (the “Indemnified Person”) of
        notice of any demand, claim or circumstances which would or might give rise
        to a
        claim or the commencement of any action, proceeding or investigation in respect
        of which indemnity may be sought pursuant to Section 8.1, such Indemnified
        Person shall promptly notify the persons or entities responsible to give
        such
        indemnity (the “Indemnitor”) in writing and the Indemnitor shall assume the
        defense thereof, including the employment of counsel reasonably satisfactory
        to
        such Indemnified Person, and shall assume the payment of all fees and expenses;
        provided,
        however,
        that
        the failure of any Indemnified Person so to notify the Indemnitor shall not
        relieve the Indemnitor of its obligations hereunder except to the extent
        that
        the Indemnitor is materially prejudiced by such failure to notify. In any
        such
        proceeding, any Indemnified Person shall have the right to retain its own
        counsel, but the fees and expenses of such counsel shall be at the expense
        of
        such Indemnified Person unless: (i) the Indemnitor and the Indemnified Person
        shall have mutually agreed to the retention of such counsel; or (ii) in the
        reasonable judgment of counsel to such Indemnified Person representation
        of both
        parties by the same counsel would be inappropriate due to actual or potential
        differing interests between them. The Indemnitor shall not be liable for
        any
        settlement of any proceeding effected without its prior written consent,
        which
        consent shall not be unreasonably withheld, but if settled with such consent,
        or
        if there be a final judgment for the plaintiff, the Indemnitor shall indemnify
        and hold harmless such Indemnified Person from and against any loss or liability
        (to the extent stated above) by reason of such settlement or judgment. Without
        the prior written consent of the Indemnified Person, which consent shall
        not be
        unreasonably withheld, the Indemnitor shall not effect any settlement of
        any
        pending or threatened proceeding in respect of which any Indemnified Person
        is
        or could have been a party and indemnity could have been sought hereunder
        by
        such Indemnified Party, unless such settlement includes an unconditional
        release
        of such Indemnified Person from all liability arising out of such
        proceeding.

      
        
          
          

        

        
          32

          
            

          

        

        
          
          

        

      

       

      9. Miscellaneous.

       

      9.1 Governing
        Law, Jurisdiction and Waiver of Jury Trial.

       

      (a) THIS
        AGREEMENT AND THE OTHER RELATED AGREEMENTS SHALL BE GOVERNED BY AND CONSTRUED
        AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE
        TO
        CONTRACTS MADE AND PERFORMED IN SUCH STATE, WITHOUT REGARD TO PRINCIPLES
        OF
        CONFLICTS OF LAWS.

       

      (b) THE
        PARTIES HEREBY CONSENT AND AGREE THAT THE STATE OR FEDERAL COURTS LOCATED
        IN THE
        COUNTY OF NEW YORK, STATE OF NEW YORK SHALL HAVE EXCLUSIVE JURISDICTION TO
        HEAR
        AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN THE COMPANY, ON THE ONE HAND,
        AND
        THE PURCHASERS, ON THE OTHER HAND, PERTAINING TO THIS AGREEMENT OR ANY OF
        THE
        RELATED AGREEMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED TO THIS AGREEMENT
        OR ANY OF THE OTHER RELATED AGREEMENTS; PROVIDED,
        THAT
        THE PURCHASERS AND THE COMPANY ACKNOWLEDGE THAT ANY APPEALS FROM THOSE COURTS
        MAY HAVE TO BE HEARD BY A COURT LOCATED OUTSIDE OF THE COUNTY OF NEW YORK,
        STATE
        OF NEW YORK. THE COMPANY EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE TO SUCH
        JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND THE COMPANY
        HEREBY WAIVES ANY OBJECTION WHICH IT MAY HAVE BASED UPON LACK OF PERSONAL
        JURISDICTION, IMPROPER VENUE OR FORUM
        NON CONVENIENS.

       

      (c) THE
        PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH
        APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION OF THE BENEFITS
        OF
        THE JUDICIAL SYSTEM AND OF ARBITRATION, THE PARTIES HERETO WAIVE ALL RIGHTS
        TO
        TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE,
        WHETHER ARISING IN CONTRACT, TORT, OR OTHERWISE BETWEEN THE PURCHASERS AND/OR
        THE COMPANY ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE
        RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION WITH THIS AGREEMENT,
        ANY
        OTHER RELATED AGREEMENT OR THE TRANSACTIONS RELATED HERETO OR
        THERETO.

       

      9.2 Severability.
        Wherever possible each provision of this Agreement and the Related Agreements
        shall be interpreted in such manner as to be effective and valid under
        applicable law, but if any provision of this Agreement or any Related Agreement
        shall be prohibited by or invalid or illegal under applicable law such provision
        shall be ineffective to the extent of such prohibition or invalidity or
        illegality, without invalidating the remainder of such provision or the
        remaining provisions thereof which shall not in any way be affected or impaired
        thereby.

      
        
          
          

        

        
          33

          
            

          

        

        
          
          

        

      

       

      9.3 Survival.
        The
        representations, warranties, covenants and agreements contained in this
        Agreement shall survive the Closing of the transactions contemplated by this
        Agreement but, subject to Section 9.11, shall terminate with respect to each
        Purchaser (or its successors or assigns) following the full conversion of
        the
        Note owned by such Purchaser (or its successors or assigns). All statements
        as
        to factual matters contained in any certificate or other instrument delivered
        by
        or on behalf of the Company pursuant hereto in connection with the transactions
        contemplated hereby shall be deemed to be representations and warranties
        by the
        Company hereunder solely as of the date of such certificate or instrument.
        All
        indemnities set forth herein shall survive the execution, delivery and
        termination of this Agreement and the Notes and the making and repayment
        of the
        obligations arising hereunder, under the Notes and under the other Related
        Agreements.

       

      9.4 Successors.
        This
        Agreement may not be assigned by a party hereto without the prior written
        consent of the Company or the Purchasers, as applicable, provided, however,
        that
        a Purchaser may assign its rights and delegate its duties hereunder in whole
        or
        in part to an affiliate or to a third party (other than a competitor of the
        Company or any of its Subsidiaries or its affiliates) acquiring some or all
        of
        its Securities in a private transaction without the prior written consent
        of the
        Company or the other Purchasers, after notice duly given by such Purchaser
        to
        the Company provided, that no such assignment or obligation shall affect
        the
        obligations of such Investor hereunder. Except as otherwise expressly provided
        herein, the provisions hereof shall inure to the benefit of, and be binding
        upon, the successors, heirs, executors and administrators of the parties
        hereto
        and shall inure to the benefit of and be enforceable by each person or entity
        which shall be a holder of the Securities from time to time. No Purchaser
        shall
        be permitted to assign its rights hereunder or under any Related Agreement
        to a
        competitor of the Company unless an Event of Default (as defined in the Note)
        has occurred and is continuing; provided that such restriction shall not
        prohibit the sale of the public sale of Securities by a Purchaser pursuant
        to
        Rule 144 or under the Registration Statement (as defined in the Registration
        Rights Agreement).

       

      9.5 Amendment
        and Waiver.

       

      (a) This
        Agreement may be amended or modified only upon the written consent of the
        Company and the Purchasers then holding a majority of the principal outstanding
        amount of the Notes (“Required Purchasers”).

       

      (b) The
        obligations of the Company and the rights of the Purchasers under this Agreement
        may be waived only with the written consent of the Required
        Purchasers.

       

      (c) The
        obligations of the Purchasers and the rights of the Company under this Agreement
        may be waived only with the written consent of the Company.

       

      9.6 Notices.
        All
        notices required or permitted hereunder shall be in writing and shall be
        deemed
        effectively given:

      
        
          
          

        

        
          34

          
            

          

        

        
          
          

        

      

       

      (a) upon
        personal delivery to the party to be notified;

       

      (b) when
        sent
        by confirmed facsimile if sent during normal business hours of the recipient,
        if
        not, then on the next business day;

       

      (c) three
        (3)
        business days after having been sent by registered or certified mail, return
        receipt requested, postage prepaid; or

       

      (d) one
        (1)
        day after deposit with a nationally recognized overnight courier, specifying
        next day delivery, with written verification of receipt.

       

      All
        communications shall be sent as follows:

       

      
        	
                If
                  to any Company,

                to:

              	
                a21,
                  Inc.

                7660
                  Centurian Parkway

                Jacksonville,
                  Florida 32256

                Attention:
                  Chief Financial Officer

                Facsimile:
                  (904) 565-1620

              
	
                With
                  a copy to:

              	
                Lloyd
                  L. Rothenberg, Esq.

                Loeb
                  & Loeb, LLP

                345
                  Park Avenue

                New
                  York, New York 10154

                Facsimile:
                  (212) 407-4990

              
	
                If
                  to any Purchaser, 

                to:

              	
                At
                  the address on the books of the
                  Company

              

      

      or
        at
        such other address as the Company or the Purchasers may designate by written
        notice to the other parties hereto given in accordance herewith.

       

      9.7 Titles
        and Subtitles.
        The
        titles of the sections and subsections of this Agreement are for convenience
        of
        reference only and are not to be considered in construing this
        Agreement.

       

      9.8 Facsimile
        Signatures; Counterparts.
        This
        Agreement may be executed by facsimile signatures and in any number of
        counterparts, each of which shall be an original, but all of which together
        shall constitute one agreement.

       

      9.9 Broker’s
        Fees.
        Each
        party hereto represents and warrants that no agent, broker, investment banker,
        person or firm acting on behalf of or under the authority of such party hereto
        is or will be entitled to any broker’s or finder’s fee or any other commission
        directly or indirectly in connection with the transactions contemplated herein.
        Each party hereto further agrees to indemnify each other party for any claims,
        losses or expenses incurred by such other party as a result of the
        representation in this Section 9.9 being untrue.

      
        
          
          

        

        
          35

          
            

          

        

        
          
          

        

      

       

      9.10 Construction.
        Each
        party acknowledges that its legal counsel participated in the preparation
        of
        this Agreement and the Related Agreements and, therefore, stipulates that
        the
        rule of construction that ambiguities are to be resolved against the drafting
        party shall not be applied in the interpretation of this Agreement or any
        Related Agreement to favor any party against the other.

       

      9.11 Termination.
        Upon
        the indefeasible payment of or full conversion of any of the Notes, this
        Agreement and all Related Agreements shall terminate, with respect to the
        Purchaser (or its successors or assigns) holding such Note. All breach of
        contract claims and indemnity provisions of any party hereto along with the
        corresponding representations, warranties and covenants, solely for the purpose
        of making such claims and indemnities, shall survive the termination of this
        Agreement.

       

      9.12 Appointment
        of Agent.
        Each
        Purchaser hereby designates and appoints Agent to act on behalf of Purchasers
        under this Agreement and the Related Agreements, including with respect to
        any
        Collateral (as defined in the Master Security Agreement) in accordance with
        the
        terms of this Agreement.

       

      9.13 Duties
        of Agent.
        Agent
        shall have the exclusive right, at the direction of Required Purchasers,
        to
        declare an Event of Default as such is described in the Notes following receipt
        by Agent of a written notice of such Event of Default from a Purchaser or
        from
        the Company (any such notice, a “Notice of Default”) and, at the direction of
        Required Purchasers, to exercise the rights and remedies of Purchasers under
        this Agreement and the Related Agreements. Upon receipt by Agent of a Notice
        of
        Default, Agent shall promptly, but in no event more than two (2) business
        days
        after receipt of such Notice of Default, notify the Company (if such Notice
        of
        Default was not received from the Company) and Purchasers of the contents
        thereof. Agent shall not be required to exercise any rights or remedies under
        this Agreement or the Related Agreements unless a Notice of Default is in
        effect
        and it shall have been directed to do so by Required Purchasers. A Notice
        of
        Default shall become effective upon receipt thereof by Agent. Required
        Purchasers shall be entitled to cancel a Notice of Default by delivering
        a
        written notice of cancellation to Agent (i) before Agent takes any action
        to
        exercise any remedy with respect to the Collateral (as defined in the Master
        Security Agreement) or (ii) thereafter, if Agent believes, in its sole
        discretion, that all actions it has taken to exercise any remedy or remedies
        with respect to the Collateral can be reversed without undue difficulty by
        returning the Collateral or the proceeds thereof or, if not reversible, if
        Company waives any rights (other than the right to have the proceeds thereof
        applied to the Obligations (as defined in the Master Security Agreement))
        in any
        Collateral or the proceeds thereof which cannot be so returned;

      
        
          
          

        

        
          36

          
            

          

        

        
          
          

        

      

       

      In
        performing its functions and duties under this Agreement and the Related
        Agreements, Agent shall act solely as an agent of Purchasers and does not
        assume
        and shall not be deemed to have assumed any obligation toward or relationship
        of
        agency or trust with or for Company or any other Person. Agent shall have
        no
        duties or responsibilities except for those expressly set forth in this
        Agreement. The duties of Agent shall be mechanical and administrative in
        nature
        and Agent shall not have, or be deemed to have, by reason of this Agreement,
        any
        Related Agreement or otherwise, a fiduciary relationship in respect of any
        Purchaser. Except as expressly set forth in this Agreement, Agent shall not
        have
        any duty to disclose, and shall not be liable for failure to disclose, any
        information relating to Company that is communicated to or obtained by Agent
        or
        any of its affiliates in any capacity.

       

      If
        Agent
        shall request instructions from Required Purchasers with respect to any act
        or
        action (including failure to act) in connection with this Agreement or any
        Related Agreement, Agent shall be entitled to refrain from such act or taking
        such action unless and until Agent shall have received instructions from
        Required Purchasers and Agent shall not incur liability to any Person by
        reason
        of so refraining. Agent shall be fully justified in failing or refusing to
        take
        any action hereunder or under any Related Agreement (i) if such action would,
        in
        the opinion of Agent, be contrary to law or the terms of this Agreement or
        any
        Related Agreement or (ii) if Agent shall not first be indemnified to its
        satisfaction against any and all liability and expense which may be incurred
        by
        it by reason of taking or continuing to take any such action.

       

      Agent
        shall promptly, but in no event more than two (2) business days after receipt
        by
        Agent, provide copies to Purchasers of any item the Agent receives pursuant
        to
        this Agreement or any of the Related Agreements including all demands, claims
        or
        notices, legal proceedings or other action taken from time to time by Agent
        pursuant to this Agreement, any of the Related Agreements or with respect
        to the
        Collateral.

       

      Agent
        may
        resign at any time and be discharged from its duties as Agent hereunder and
        under the Master Security Agreement and the Stock Pledge Agreement by its
        giving
        the Purchasers and the Company written notice and such resignation shall
        become
        effective at such time that a successor agent shall be appointed by the Required
        Purchasers. If no new agent is so appointed within the 60 day period following
        the giving of such notice of resignation, Agent may resign and the holder
        of the
        Note with the highest principal amount outstanding at such time shall
        automatically become Agent. 

       

      9.14 Application
        of Proceeds.
        Notwithstanding anything to the contrary contained in the Related Agreements,
        the proceeds realized from the sale of any Collateral shall be applied as
        follows: first,
        to the
        reasonable costs, expenses and attorneys’ fees and expenses incurred by Agent
        for collection and for acquisition, completion, protection, removal, storage,
        evaluation, sale and delivery of the Collateral; secondly,
        to any
        fees or expenses of Agent that any Purchaser has advanced or which it is
        entitled, pursuant to this Agreement or any Related Agreement, to receive;
        and
thirdly,
        to the
        unpaid principal and interest on the Notes then outstanding and if such money
        shall be insufficient to pay such amounts in full, then ratably (without
        priority of any one over the other) to Purchasers in proportion to the unpaid
        amount thereof on such date. If any surplus exists, such surplus shall be
        held
        as cash Collateral pending full payment and satisfaction of all Obligations,
        after which any remainder shall be returned to Company unless Agent or any
        Purchaser is then otherwise required to remit such remainder under applicable
        law.

      
        
          
          

        

        
          37

          
            

          

        

        
          
          

        

      

       

      9.15 Actions
        in Concert.
        Anything in this Agreement or the Related Agreements to the contrary
        notwithstanding, to the extent Agent or Required Purchasers have the right
        to
        take or cause to be taken any action or enforcement, each Purchaser hereby
        agrees with each other Purchaser that no Purchaser shall take any such action
        to
        protect or enforce its rights arising out of this Agreement, the Notes or
        the
        other Related Agreements (including exercising any rights of setoff) without
        first obtaining the prior written consent of Agent and Required Purchasers,
        it
        being the intent of Purchasers that any such action to protect or enforce
        such
        rights under this Agreement, the Notes and the other Related Agreements shall
        be
        taken in concert and at the direction or with the consent of Agent or Required
        Purchasers, as applicable.

       

      9.16 Agent’s
        Indemnity.

       

      Neither
        Agent nor any director, officer, employee, attorney, agent or representative
        of
        Agent shall be liable to any Purchaser for any action taken or omitted to
        be
        taken by it or them hereunder or under any Related Agreement, except for
        damages
        caused by its or their own gross negligence or willful misconduct, nor shall
        Agent be responsible for the validity, effectiveness or sufficiency of any
        Related Agreement or of any document or security furnished pursuant thereto
        or
        hereto. Without limiting the generality of the foregoing, Agent: (a) may
        treat
        the payee of any Note as Purchasers thereof until Agent receives written
        notice
        of the assignment or transfer thereof signed by such payee and in form
        reasonably satisfactory to Agent; (b) may consult with legal counsel,
        independent public accountants and other experts selected by it and shall
        not be
        liable for any action taken or omitted to be taken by it in good faith in
        accordance with the advice of such counsel, accountants or experts; (c) makes
        no
        warranty or representation to any Purchaser except as set forth in this
        Agreement and shall not be responsible to any Purchaser for any statements,
        warranties or representations made in or in connection with the Related
        Agreements; (d) shall not have any duty to ascertain or to inquire as to
        the
        performance or observation of any of the terms, covenants or conditions of
        this
        Agreement or the Related Agreements or to inspect the Collateral (including
        the
        books and records); (e) shall not be responsible to any Purchasers for the
        due
        execution, legality, validity, enforceability, genuineness, sufficiency or
        value
        of this Agreement, the Related Agreements or any other instrument or document
        furnished pursuant thereto; and (f) shall incur no liability under or in
        respect
        of this Agreement or the Related Agreements by acting upon any notice, consent,
        certificate or other instrument or writing (which may be by telecopy, telegram,
        cable or telex) believed by it to be genuine and signed or sent by the proper
        party or parties.

      
        
          
          

        

        
          38

          
            

          

        

        
          
          

        

      

       

      Purchasers
        agree to indemnify Agent, ratably according to their respective pro rata
        shares
        of the Notes, from and against any and all obligations, losses, damages,
        penalties, actions, judgments, suits, costs, expenses or disbursements of
        any
        kind or nature whatsoever that may be imposed on, incurred by, or asserted
        against Agent in any way relating to or arising out of this Agreement or
        any
        Related Agreement or any action taken or omitted to be taken by Agent in
        connection herewith or therewith; provided,
        that no
        Purchaser shall be liable for any portion of such obligations, losses, damages,
        penalties, actions, judgments, suits, costs, expenses or disbursements resulting
        from Agent’s gross negligence or willful misconduct. Without limiting the
        foregoing, each Purchaser agrees to reimburse Agent promptly upon demand
        for its
        ratable share of any out-of-pocket expenses (including reasonable counsel
        fees)
        incurred by Agent in connection with the administration, modification, amendment
        or enforcement (whether through negotiations, legal proceedings or otherwise)
        of, or legal advice in respect of rights or responsibilities under, this
        Agreement and each Related Agreement.

       

      9.17 Agent
        and Affiliates.
        Agent
        and its affiliates may lend money to, invest in, and generally engage in
        any
        kind of business with, Company, any of its affiliates and any Person who
        may do
        business with or own securities of any Company or any such affiliate, all
        as if
        Agent were not Agent and without any duty to account therefor to
        Purchasers.

       

      9.18 Purchaser
        Decisions.
        Each
        Purchaser also acknowledges that it will, independently and without reliance
        upon Agent and based on such documents and information as it shall deem
        appropriate at the time, continue to make its own credit decisions in taking
        or
        not taking action under this Agreement or any Related Agreement. Each Purchaser
        acknowledges the potential conflict of interest of each other Purchaser as
        a
        result of Purchasers holding disproportionate interests in the Notes, and
        expressly consents to, and waives any claim based upon, such conflict of
        interest.

       

      9.19 Confidential
        Information.

       

      (a) Each
        Purchaser acknowledges that all Confidential Information (as defined below)
        provided by the Company, its Subsidiaries or its agents and representatives
        (the
“Delivering Party”) to each Purchaser, or its respective agents and
        representatives (the “Receiving Party”) constitutes confidential and proprietary
        information of the Company and its Subsidiaries. As used herein, “Confidential
        Information” means all information that is furnished by the Delivering Party to
        the Receiving Party which relates to the Company, its Subsidiaries and their
        respective business concepts and plans, data, documentation and/or control
        information, financial information, formulations, techniques, trade secrets,
        proprietary technical information, business and marketing analyses and plans,
        and which is either confidential, proprietary in nature or otherwise not
        generally available to the public.

      
        
          
          

        

        
          39

          
            

          

        

        
          
          

        

      

       

      (b) Any
        information furnished to a Receiving Party by a director, officer, employee,
        advisor or agent of the Company or any of its Subsidiaries shall be deemed
        Confidential Information for the purpose of this Agreement. Confidential
        Information received hereunder shall not be used for commercial or competitive
        benefit by the Receiving Party and such party shall keep Confidential
        Information confidential and shall cause its respective directors, officers,
        employees, agents, accountants and attorneys to keep Confidential Information
        confidential unless such party is required to disclose such Confidential
        information by
        applicable law, court order or through legal process (by oral questions,
        interrogatories, requests for information or documents, subpoena, civil
        investigative demand, national
        securities exchange demand
        or
        similar process).
        The
        obligations of each Receiving Party shall include the obligation to take
        all
        steps reasonably necessary to protect the confidentiality of Confidential
        Information and to prevent the disclosure thereof and shall survive the
        termination of this Agreement provided, that any Purchaser may disclose
        Confidential Information to its investors and prospective investors in the
        ordinary course of business consistent with past practice so long as such
        investors agree to keep such Confidential Information to the extent such
        Purchaser is required to do so hereunder. Notwithstanding the foregoing,
        the
        following will not constitute Confidential Information for the purposes of
        this
        Agreement; (i) information which is or becomes generally available to the
        public
        other than as a result of a disclosure by the Receiving Party, (ii) information
        which becomes available to the Receiving Party on a nonconfidential basis
        from a
        source other than the Delivering Party if such source was not subject to
        any
        prohibition against transmitting the information to the Receiving Party or
        (iii)
        was
        within a party's possession prior to its being furnished by or on behalf
        of the
        furnishing party.

       

      9.20 Publicity.
        Except
        as set forth below, no public release or announcement concerning the
        transactions contemplated hereby shall be issued by the Company or the
        Purchasers without the prior consent of the Company (in the case of a release
        or
        announcement by the Purchasers) or the Purchasers (in the case of a release
        or
        announcement by the Company) (which consents shall not be unreasonably
        withheld), except as such release or announcement may be required by law
        or the
        applicable rules or regulations of any securities exchange or securities
        market,
        in which case the Company or the Purchasers, as the case may be, shall allow
        the
        Purchasers or the Company, as applicable, to the extent reasonably practicable
        in the circumstances, reasonable time to comment on such release or announcement
        in advance of such issuance. By 8:30 a.m. (New York City time) on the trading
        day immediately following the Closing Date or by such other time as agreed
        to by
        Agent and a21, a21 shall issue a press release disclosing the consummation
        of
        the transactions contemplated by this Agreement. No later than the date it
        is
        required to do so pursuant to applicable law, a21 will file a Current Report
        on
        Form 8-K attaching the press release described in the foregoing sentence
        as well
        as copies of the Related Agreements. In addition, the Company will make such
        other filings and notices in the manner and time required by the SEC.
        Notwithstanding the foregoing, the Company shall not publicly disclose the
        name
        of any Purchaser, or include the name of any Purchaser in any filing with
        the
        SEC (other than the Registration Statement and any exhibits to filings made
        in
        respect of this transaction in accordance with periodic filing requirements
        under the Exchange Act) or any regulatory agency, without the prior written
        consent of such Purchaser, except to the extent such disclosure is required
        by
        law or trading market regulations, in which case the Company shall provide
        the
        Purchasers with prior notice of such disclosure.

      
        
          
          

        

        
          40

          
            

          

        

        
          
          

        

      

       

      9.21 Expenses.
        The
        parties hereto shall pay their own costs and expenses in connection herewith,
        except that the Company shall pay the reasonable fees and expenses of the
        Purchasers not to exceed $65,000 in the aggregate. Such expenses shall be
        paid
        not later than the Closing. In the event that legal proceedings are commenced
        by
        any party to this Agreement against another party to this Agreement in
        connection with this Agreement or the other Related Agreements, the party
        or
        parties which do not prevail in such proceedings shall severally, but not
        jointly, pay their pro rata share of the reasonable attorneys’ fees and other
        reasonable out-of-pocket costs and expenses incurred by the prevailing party
        in
        such proceedings.

       

      9.22 Independent
        Nature of Purchasers' Obligations and Rights.
        The
        obligations of each Purchaser under this Agreement and any Related Agreement
        are
        several and not joint with the obligations of any other Purchaser, and no
        Purchaser shall be responsible in any way for the performance of the obligations
        of any other Purchaser under any Related Agreement. The decision of each
        Purchaser to purchase Securities pursuant to the Related Agreements has been
        made by such Purchaser independently of any other Purchaser. Nothing contained
        herein or in any Related Agreement, and no action taken by any Purchaser
        pursuant thereto, shall be deemed to constitute the Purchasers as a partnership,
        an association, a joint venture or any other kind of entity, or create a
        presumption that the Purchasers are in any way acting in concert or as a
        group
        with respect to such obligations or the transactions contemplated by the
        Related
        Agreements. Each Purchaser acknowledges that no other Purchaser has acted
        as
        agent for such Purchaser in connection with making its investment hereunder
        and
        that no Purchaser will be acting as agent of such Purchaser in connection
        with
        monitoring its investment in the Securities or enforcing its rights under
        the
        Related Agreements. Each Purchaser shall be entitled to independently protect
        and enforce its rights, including, without limitation, the rights arising
        out of
        this Agreement or out of the other Related Agreements, and it shall not be
        necessary for any other Purchaser to be joined as an additional party in
        any
        proceeding for such purpose. The Company acknowledges that each of the
        Purchasers has been provided with the same Related Agreements for the purpose
        of
        closing a transaction with multiple Purchasers and not because it was required
        or requested to do so by any Purchaser.

       

      9.23
         Equal
        Treatment of Purchasers.
        No
        consideration shall be offered or paid to any person to amend or consent
        to a
        waiver or modification of any provision of this Agreement and the other
        transaction documents contemplated hereby unless the same consideration is
        also
        offered to all of the parties to this Agreement and the other transaction
        documents contemplated hereby. For clarification purposes, this provision
        constitutes a separate right granted to each Purchaser by the Company and
        negotiated separately by each Purchaser, and is intended to cause the Company
        to
        treat the Purchasers as a class and shall not in any way be construed as
        the
        Purchasers acting in concert or as a group with respect to the purchase,
        disposition or voting of Securities or otherwise.

       

      

       

      [THE
        REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

      
        
          
          

        

        
          41

          
            

          

        

        
          
          

        

      

       

      IN
        WITNESS WHEREOF, the parties hereto have executed the SECURITIES PURCHASE
        AGREEMENT as of the date set forth in the first paragraph hereof.

      

      
        	
                COMPANIES:

              	 
	 	 
	
                a21,
                  INC.

              	 
	
                By:
                  /s/ Tom Constanza

              	 
	
                Name:
                  Tom Constanza

              	 
	
                Title:
                  VP CFO

              	 
	 	 
	
                SUPERSTOCK,
                  INC.

              	 
	 	 
	
                By:
                  /s/ Tom Constanza

              	 
	
                Name:
                  Tom Constanza

              	 
	
                Title:
                  EVP CFO

              	 
	 	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          42

          
            

          

        

        
          
          

        

      

       

      
        	
                PURCHASER
                  AND AGENT:

              	 
	 	 
	
                QUEEQUEG
                  PARTNERS, L.P. By: Queequeg GP, LLC, its General Partner

              	 
	
                By:
                  /s/ Jonathan Gallen

              	 
	
                Name:
                  Jonathan Gallen

              	 
	
                Title:
                  Managing Member

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          43

          
            

          

        

        
          
          

        

      

       

      
        	
                PURCHASER:

              	 
	 	 
	
                QUEEQUEG,
                  LTD

              	 
	
                By:
                  /s/ Jonathan Gallen

              	 
	
                Name:
                  Jonathan Gallen

              	 
	
                Title:
                  President

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          44

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                JOHN
                  L. STEFFENS

              	 
	    /s/
                John L. Steffens	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          45

          
            

          

        

        
          
          

        

      

      
 

      
        	
                PURCHASER:

              	 
	 	 
	
                ROBERT
                  M. BARKER

              	 
	/s/ Robert
                M. Barker	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          46

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                STARVEST
                  PARTNERS, L.P. By: StarVest Associates, LLC, its General
                  Partner

              	 
	
                By:
                  /s/  Laura B. Sachar

              	 
	
                Name:
                  Laura B. Sachar

              	 
	
                Title:
                  Managing Member

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          47

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                COHANZICK
                  CREDIT OPPORTUNITIES 

                MASTER
                  FUNDS LTD., By: David K. Sherman

              	 
	
                By:
                  /s/ David K. Sherman

              	 
	
                Name:
                  David K. Sherman

              	 
	
                Title:
                  Agent

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          48

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                WEISKOPF,
                  SILVER & CO., L.P., By: William Silver Securities, Inc., its General
                  Partner

              	 
	 	 
	
                By:
                  /s/ William Silver

              	 
	
                Name:
                  William Silver

              	 
	
                Title:
                  President

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          49

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                LEWIS
                  C. PELL

              	 
	/s/
                Lewis C. Pell	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          50

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                RICHARD
                  NESLUND

              	 
	/s/
                Richard Neslund	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      

      
        
          
          

        

        
          51

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                LEONARDO,
                  L.P.,
                  By: Leonardo Capital Management, Inc., Its General Partner, By:
                  Angelo,
                  Gordon & Co., L.P., Its Director

              	 
	 	 
	
                By:
                  /s/ Michael L. Gordon

              	 
	
                Name:
                  Michael L. Gordon

              	 
	
                Title:
                  Chief Operating Officer

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      
        
          
          

        

        
          52

          
            

          

        

        
          
          

        

      

       

      

      
        	
                PURCHASER:

              	 
	 	 
	
                MORGAN
                  STANLEY & CO. INCORPORATED

              	 
	 	 
	
                By:
                  /s/ Thomas Doster, MD

              	 
	
                Name:
                  Thomas Doster

              	 
	
                Title:
                  

              	 

      

       

      [SIGNATURES
        CONTINUED ON FOLLOWING PAGE]

      

      
        
          
          

        

        
          53

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        A

      

       

      LIST
        OF INITIAL PURCHASERS

       

      Queequeg
        Partners, L.P., By: Queequeg Gp, Llc, Its General Partner

       

      Queequeg,
        Ltd

       

      John
        L.
        Steffens

       

      Robert
        M.
        Barker

       

      Starvest
        Partners, L.P., By: Starvest Associates, LLC, Its General Partner

       

      Cohanzick
        Credit Opportunities Master Funds Ltd., By: David K. Sherman

       

      Weiskopf,
        Silver & Co., L.P., By: William Silver Securities, Inc., Its General
        Partner

       

      Lewis
        C.
        Pell

       

      Richard
        Neslund

       

      Leonardo,
        L.P., By: Leonardo Capital Management, Inc., Its General Partner

       

      Morgan
        Stanley & Co. Incorporated, Fixed Income Division, Strategic Investments
        Group

      
        
          
          

        

        
          54

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        B

       

      FORM
        OF INITIAL CONVERTIBLE NOTE

       

      [See
        Attached]

      
        
          
          

        

        
          55

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        C

       

      FORM
        OF FUTURE CONVERTIBLE TERM NOTE

       

      [See
        Attached]

      
        
          
          

        

        
          56

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.2

       

      SUBSIDIARIES

      
        	 	 	 	 
	
                Subsidiary

              	
                Jurisdiction

              	
                Owner

              	
                %Ownership

              
	
                SuperStock,
                  Inc.

              	
                Florida

              	
                a21,
                  Inc.

              	
                83.33%

              
	
                SuperStock
                  Canada Inc.

              	
                Canada

              	
                SuperStock,
                  Inc.

              	
                100%

              
	
                SuperStock
                  Limited

              	
                U.K.

              	
                SuperStock,
                  Inc.

              	
                100%

              
	
                LCJ
                  Acquisition Limited

              	
                U.K.

              	
                SuperStock
                  Limited

              	
                100%

              
	
                Ingram
                  1001 Limited

              	
                U.K.

              	
                LCJ
                  Acquisition Limited

              	
                100%

              
	
                Ingram
                  Publishing Limited

              	
                U.K.

              	
                Ingram
                  1001 Limited

              	
                100%

              
	
                a21
                  Acquisition LLC (inactive)

              	
                Delaware

              	
                a21,
                  Inc.

              	
                100%

              
	
                Agence
                  21, Inc.(inactive)

              	
                Delaware

              	
                a21
                  Acquisition LLC

              	
                84.3%

              

      

       

      
        
          
          

        

        
          57

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.3

       

      CAPITALIZATION

      
        	 	 	 	 	 
	
                Subsidiary

              	
                Authorized
                  Common

              	
                Issued
                  and Outstanding Common

              	
                Authorized
                  Preferred

              	
                Issued
                  and Outstanding

              
	
                SuperStock,
                  Inc.

              	
                10,000,000

              	
                8,333,282

              	
                10,000,000

              	
                Preferred

              
	
                SuperStock
                  Canada Inc.

              	
                20,000

              	
                20,000

              	 	
                1,666,717

              
	
                SuperStock
                  Limited

              	
                100

              	
                100

              	 	 
	
                LCJ
                  Acquisition Limited

              	
                200,000

              	
                100,000

              	
                300,000

              	 
	
                Ingram
                  1001 Limited

              	
                1,000

              	
                1,000

              	 	
                300,000

              
	
                Ingram
                  Publishing Limited

              	
                1,000

              	
                499

              	 	 
	
                a21
                  Acquisition LLC (inactive)

              	
                -

              	 	 	 
	
                Agence
                  21, Inc.(inactive)

              	
                40,000,000

              	
                4,887,000

              	
                10,000,000

              	 

      

       

      
        
          
          

        

        
          58

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.7

      

       

      AGREEMENTS

       

      None

      
        
          
          

        

        
          59

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.8

      

       

      OBLIGATIONS
        TO RELATED PARTIES

       

      None

      
        
          
          

        

        
          60

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.9

      

       

      CHANGES

       

      Changes
        to composition of senior management of SuperStock,
        Inc.

      
        	 	 	 
	 	
                Employment
                  Date

              	
                Termination
                  Date

              
	
                Paul
                  Ryall - VP Marketing

              	
                2/28/2005

              	
                1/20/2006

              
	
                Susan
                  O’Brien - VP Global Channel  (UK)

              	
                6/1/2005

              	
                -

              
	
                Bruce
                  Haertlein - VP Sales

              	
                -

              	
                2/8/2005

              
	
                Candice
                  Crough - VP Sales

              	
                10/26/2005

              	
                -

              
	
                Kai
                  Chiang - SVP Market Development

              	
                -

              	
                7/29/2005

              
	
                Ian
                  Lishman - VP Visual Content (UK)

              	
                -

              	
                2005

              
	
                Ellen
                  Boughn - VP Content Strategy

              	
                2/1/2006

              	
                -

              

      

       

      
        
          
          

        

        
          61

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.10

      

       

      PROPERTIES

       

      None

      
        
          
          

        

        
          62

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.13

      

       

      LITIGATION

       

      None

      
        
          
          

        

        
          63

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.15

      

       

      TAX
        RETURNS AND PAYMENTS

       

      None

      
        
          
          

        

        
          64

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.16

       

       

      EMPLOYEES

       

      Ellen
        Boughn - Employment Agreement dated 2/1/2006 - severance of up to 4 months
        salary for termination without cause.

      
        
          
          

        

        
          65

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.17

      

       

      REGISTRATION
        RIGHTS AND VOTING RIGHTS

       

      None

      
        
          
          

        

        
          66

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.22

      

       

      SEC
        REPORTS

       

      None

      
        
          
          

        

        
          67

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        4.28

      

       

      INTERNAL
        CONTROLS

       

      a21’s
        financial statements were not completed and could not be completed within
        the
        prescribed time period due to the financial reporting integration and separate
        stand-alone audit of UK-based SuperStock Limited financial statements, including
        the Ingram Publishing Ltd., which was acquired in October 2005.

      
        
          
          

        

        
          68

          
            

          

        

        
          
          

        

      

       

      SCHEDULE
        6.10(d)

      

       

      INDEBTEDNESS

       

      None

      
        
          
          

        

        
          69

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]